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Abstract 
Fortified-blended foods (FBFs), grain-legume porridges (most commonly corn and soy), 
are frequently used for food aid purposes. Sorghum and cowpea have been suggested as 
alternative FBF commodities because they are drought-tolerant, grown locally in food aid 
receiving countries, and are not genetically modified.  
The objective of this thesis was to determine the protein quality and iron bioavailability 
of newly formulated, extruded FBFs in broiler chickens, which have been suggested as a good 
model for assessing iron bioavailability. Five FBFs were formulated to contain whey or soy 
protein to compare protein quality, sugar, oil, and an improved micronutrient premix. These 
included three white sorghum-cowpea FBFs; two were extruded with either whey protein 
concentrate (WSC) or soy protein isolate (WSC+SPI) added, one was non-extruded (N-WSC). 
Two others were white sorghum-soy (WSS) and corn-soy (CSB14) FBFs. Two additional white-
sorghum cowpea FBFs were reformulated and “over-processed” to contain no sugar, less whey 
(O-WSC) or soy protein (O-WSC+SPI), and less oil, thus producing a less expensive FBF. Two 
studies were performed using prepared (Prep) or dry (Dry) FBFs, along with the United States 
Agency for International Development (USAID) corn and soy blend FBF, CSB+, fed to chickens 
for 3 and 2 weeks, respectively; food intake, body weights, hemoglobin, and hepatic iron were 
assessed.  
In the Prep study, new FBFs significantly increased caloric and protein efficiency 
compared to CSB+, despite similar food intake and body weight gain. In the Dry study, CSB+ 
significantly decreased food intake and caloric efficiency, with the exception of O-WSC+SPI, 
and nonsignificantly reduced body weight gain and protein efficiency compared to new FBFs. 
  
CSB+ significantly reduced hepatic iron content compared to all FBFs in the Dry study, and was 
nonsignificantly decreased compared to new FBFs in the Prep study. 
In conclusion, sorghum and cowpea FBFs performed similarly to corn and soy FBFs, 
suggesting these commodities are suitable replacements for corn and soy. Soy protein isolate 
(WSC+SPI) was an effective alternative to whey protein concentrate (WSC), suggesting SPI can 
be a less expensive protein supplement in FBFs. Surprisingly, non-extruded sorghum and 
cowpea (N-WSC) was equally efficacious to extruded WSC. However, N-WSC did not meet 
viscosity requirements and is not precooked, which limits its viability as an FBF. O-WSC+SPI 
resulted in poorer outcomes compared to other FBFs, which suggests the protein quality of 
cowpea may be inferior and the inclusion of whey protein is needed in this formulation, as O-
WSC with whey performed similarly to other FBFs. Overall, new FBFs, with the exception of O-
WSC+SPI, resulted in improved food efficiency and hepatic iron outcomes compared to CSB+, 
suggesting they are of higher nutritional quality. However, further research is needed to refine 
and identify the best FBF formulations. 
This project was funded by the United States Department of Agriculture (USDA) Foreign 
Agricultural Service under the Micronutrient Fortified Food Aid Products Pilot (MFFAPP) 
program, contract number #FFE-621-2012/033-00. 
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Chapter 1 - Background Information 
 Protein-Energy Malnutrition 
 Prevalence 
793 million people globally are still undernourished, despite a decrease of 216 million 
over the last decade (1). The United Nations Children's Fund (UNICEF) estimates that half of 
under-five child deaths are due to undernutrition (3 million per year; 2). Undernutrition includes 
protein-energy malnutrition (PEM), which encompasses a group of disorders that include 
marasmus (inadequate protein and calorie intake, characterized by emaciation), kwashiorkor 
(inadequate protein intake with adequate calorie intake, characterized by edema), wasting, 
stunting, and underweight as well as mild, moderate, or severe acute malnutrition (SAM; edema 
presence); these conditions collectively contribute to the global prevalence of undernutrition (3). 
Stunting is the irreversible cause of chronic malnutrition associated with impaired cognition and 
work performance (2). In 1990-2015, stunting prevalence declined from 39.6 percent to 23.2 
percent, however this still equates to 156 million children (2). Wasting is a form of acute 
malnutrition due to rapid weight loss or inability to gain weight, characterized by low weight for 
height. There are 50 and 17 million children globally who are wasted and severely wasted, 
respectively (2). Most stunted and wasted children reside in Africa and Asia, where the annual 
GDP losses near 11 percent due to malnutrition (4).  
 Causes 
Many factors contribute to undernutrition including lack of education, child feeding 
practices, clean water and sanitation, as well as hygiene, gender inequality, and lack of access to 
healthcare (4, 5). However, poverty is the primary cause of undernutrition, which explains why 
the majority of undernutrition primarily occurs in low and middle income countries (2, 6). 
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In regard to protein-energy malnutrition, children with edematous kwashiorkor and 
marasmic-kwashiorkor may not be able to maintain body protein breakdown as those with non-
edematous marasmus might, resulting in less amino acid supply for plasma proteins (albumin) 
for nutrient transport and acute phase response to infection, leading to higher morbidity and 
mortality rates (7). Edema presence occurs from excess accumulation of fluid in extracellular 
spaces due to capillary fluid filtration exceeding reabsorption (8). 
Another determinant of PEM may be the availability of protein from certain foods. 
Dietary utilizable protein, rather than crude protein intake, may provide a better reflection of 
protein inadequacy prevalence or population impact risk (9), therefore is it important to provide 
highly utilizable protein in PEM treatments. The costly inclusion of whey protein concentrate in 
PEM treatments such as in food aid products has been questioned (10), and there is still little 
evidence to support whether plant versus animal source proteins are more adequate for PEM 
treatment (11). 
 Protein quality measurements 
The protein quality measurement previously recommended by FAO/WHO is the protein 
digestibility-corrected amino acid score (PDCAAS), which assesses protein quality based on the 
limiting amino acid score and its fecal digestibility to meet demands for amino acid utilization 
from dietary protein in a specific reference group (12). Limitations have been identified, which 
include the method overestimating product protein quality with antinutritional factors, poorly 
reflecting amino acid usage beyond the terminal ileum by using fecal digestibility, lack of 
distinction between higher quality proteins due to value truncation at 100%, and validity of 
reference patterns (12, 13). The digestible indispensable amino acid score (DIAAS) has been 
recommended to replace the PDCAAS to address these limitations (12). This method allows for 
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better individual amino acid digestibility measurements from foods using ileal digesta, does not 
use a truncated score, and uses better defined reference patterns (12).  
 Iron Deficiency Anemia 
 Prevalence 
Undernutrition also includes micronutrient deficiencies (MNDs). MNDs are often called 
“hidden hunger” because they can cause significant health impairment without displaying acute 
symptoms, but chronically increase growth, cognition and disease risk (14). Iron, iodine, vitamin 
A, folate and zinc, are the most predominant MNDs; iron deficiency is the most prevalent 
globally (14). Two billion people worldwide are anemic (30%), half of anemia prevalence is due 
to iron deficiency (15, 16). Iron (Fe) is essential for oxygen transport and cellular respiration by 
being a component of hemoglobin, myoglobin, enzymes, and cytochromes, which ultimately 
allows for optimal growth and cognitive function (6). The global age-standardized anemia 
prevalence has decreased by 21 percent from 1990 to 2013, however iron deficiency anemia 
(IDA) only improved by 4 percent during the same timeframe (17). The most vulnerable 
populations at risk for IDA are children under five, pregnant women, and all women of 
reproductive age (15 – 49 years) (6, 15, 16), and in 2011 an estimated 42.6% of under-five 
children, 38.2% of pregnant women, and 29.0% of non-pregnant women were anemic, although 
this is not specifically for IDA, this still translates to 528.7 and 273.2 million women and 
children, respectively (18). Geographically, the highest rates of IDA are in Africa where 62.3% 
of children are anemic; in South-East Asia 48.7 and 41.5% of pregnant and non-pregnant 
women, respectively, are anemic (18). Iron deficiency anemia consequences include maternal 
death, impaired physical and cognitive development, increased morbidity and mortality risk in 
children, and decreased work productivity in adults (6, 16). Iron deficiency alone results in the 
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highest rates of anemia-related disability (17). In 1994, the median annual economic loss due to 
IDA in 10 developing countries was averaged at $16.78 per capita (19). 
 Causes 
Iron deficiency anemia can be caused by numerous interconnected individual and societal 
determinants. Individual-level determinates include inadequate iron intake or poor 
bioavailability, along with increased iron requirements during growth (19). Children become 
vulnerable to IDA because of increased iron requirements due to rapid red cell expansion (19). 
Women of reproductive age lose iron via blood loss in menstruation and childbirth, and 
increased fetal and placental iron requirements during pregnancy (19). Parasitic infections and 
infectious diseases such as malaria, tuberculosis, and HIV are other individual-level anemia risk 
factors (16). Beyond acute biological and infectious disease burden, several chronic diseases 
such as chronic kidney disease, chronic heart failure, cancer, and inflammatory bowel disease 
have been linked to IDA (15).  
 Non-heme iron absorption and regulation 
Iron is needed for either functional, storage, or transport purposes in the body. The 
primary use for functional iron is for hemoglobin (Hb), an iron containing protein in red blood 
cells responsible for transporting oxygen through circulation. There are two forms of iron, heme 
and non-heme, both are not highly bioavailable (12-25% and <5%, respectively) (6). Non-heme 
iron is primarily found in plant and iron-fortified foods, and recommended dietary allowances 
(RDAs) for iron are as high as 18 mg per day for women 19-50 years (20). It has been estimated 
that 1 to 2 mg of iron per day is lost due to enterocyte sloughing, daily dietary iron absorption 
aims to balance this loss (21). Iron recycling from senescent red blood cells also meets most of 
the iron needs in a healthy adult (22). Most dietary iron is found in the oxidized ferric form, 
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which has low bioavailability, and therefore is reduced to its ferrous form by duodenal 
cytochrome B (DcytB) (22). Ferrous iron is transported into the apical cell membrane of the 
enterocyte by divalent metal ion transporter 1 (DMT-1) (22). Iron is then either stored within 
cytoplasmic ferritin, or ferroportin (FPN1) exports iron across the basolateral membrane of the 
enterocyte and into circulation (22). In circulation, hephaestin oxidizes ferrous iron back to its 
ferric form to bind to plasma transferrin for transport and tissue-level utilization (22). Iron does 
not have regulated mechanisms for excretion, therefore absorption is controlled systematically by 
the liver hormone hepcidin, and at the tissue level (22). 
 Factors affecting iron absorption 
Many factors affect iron absorption, primary factors include pH, inhibitors such as 
phytates and tannins, enhancers such as ascorbic acid, and competitors such as lead (23). Lower 
pH has been cited to increase iron absorption by enhancing its solubility (23). Inhibitors chelate 
iron and prevent absorption, however a systematic review reported this effect may be not so clear 
(24). Enhancers such as ascorbate reduce iron to its more available form, ferrous iron, thus 
increasing uptake, while competitors compete for the same uptake mechanism, thus decreasing 
absorption (23).  
 Measurements 
Iron can be categorized into functional, circulating and storage iron (25). In conditions of 
negative iron balance, storage iron is first depleted (iron depletion), which then leads to depletion 
of circulating iron (iron deficiency), and finally iron anemia is present when functional iron is 
depleted further (25). Interventions for iron deficiency analysis, and thus iron assessment, can be 
divided into population vs individual level analysis. Often times, the cost required for assessing 
individual iron measurements is too high, therefore more feasible assessments aimed at the 
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population level are used. According to a WHO and CDC joint consultation on iron status 
assessment, hemoglobin concentration is the primary measurement for severity of iron deficiency 
at the population level (26). WHO criteria for anemia in adults, children 6 months to 6 years, and 
children 6 to 14 years are 12.5, 11.0, and 12.0 g/dL, respectively (27). Serum ferritin and 
transferrin receptor are biomarkers that allow for an accurate measurement of iron status at the 
individual level, however, ferritin levels increase during inflammatory states, such as in response 
to infectious disease in developing countries. Transferritin receptor does not increase during 
inflammatory states, which gives context to ferritin levels (26). In response to an intervention, 
serum ferritin is the best indicator of effect on iron deficiency and should be measured with 
hemoglobin (26). 
 Food Assistance 
 Global food assistance 
In 2012, more than 5 million metric tons of food aid was delivered globally (28). Food 
assistance is used to combat undernutrition in emergency settings and among vulnerable 
populations including children, pregnant women, and those with tuberculosis or HIV/AIDS. 
Types of food assistance include cash or food vouchers, cash transfers for food, and local and 
regional purchase (29). Food aid distributed by the USA is delivered as in-kind food aid under 
Tittle II which provides the supply chain for procuring commodities, processing them, then 
shipping them to the recipient country (29). The United State Agency for International 
Development (USAID) is the largest provider of food assistance globally, and in 2015 provided 
over $2.5 billion in funding which included 1.2 million metric tons of in-kind food assistance 
(30). In 2012, Sub-Saharan Africa received 63% of food assistance, totaling 3.14 million metric 
tons (28). 
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 Types of food aid products 
Food aid products are meant to prevent, or treat, different types of undernutrition, 
primarily as a supplement to the regular diet, and consist of ready-to-use therapeutic foods 
(RUTFs), high energy biscuits, micronutrient powders (sprinkles), compressed food bars, and the 
most common product, fortified blended foods (FBFs) (31). RUTFs are lipid-based, nutrient-
dense, peanut butter-like products used to treat moderate malnutrition, primarily in emergency 
settings (31). High energy biscuits, micronutrient powders, and compressed food bars are less 
commonly distributed, but provide a ready-to-eat protein and micronutrient fortified supplement 
when resources for food preparation are scarce (31). 
 Fortified blended foods 
FBFs are cereal-legume based, micronutrient-fortified, partially precooked porridge 
products used to supplement adequate protein (31). FBFs were originally developed by the USA 
in the 1960s as a corn soy milk to supply 25% of the energy needs of preschool-aged children in 
developing countries (32). In the 1980s, the first corn soy blend (CSB) was introduced as a “one-
size-fits-all” product for diverse population groups, and since then no significant updates have 
been made in its formulation and processing (32). The current most widely used USAID FBF, 
corn-soy blend plus (CSB+), incorporates heat-treated corn and soybeans with a vitamin-mineral 
premix and is recommended to be consumed with fortified vegetable oil (33). It is intended for 
complementary use by children 6-24 months, and pregnant and lactating women, to prevent 
micronutrient deficiencies, wasting, and stunting (33).  It can also be used for the treatment of 
moderate malnutrition among 6-59 month old children (33). FBFs have been shown to be a more 
cost-effective option compared to an RUTF in the treatment of MAM (34). 
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 Recommendations to improve FBFs 
In 2011, the USAID/Tufts University Food Aid Quality Review (FAQR) Report was 
published to outline recommendations for improving food assistance provided by the US, 
specifically focusing on FBFs (35). The primary purpose for FBFs are that they should be 
“energy-dense and rich in micronutrients, easily digestible and palatable, and able to be prepared 
relatively quickly, i.e., with minimal cooking” (35). Therefore, the primary recommendations to 
improve FBFs were centered on these three product purposes. These improvements include 
upgrading the macro and micronutrient content, using more culturally acceptable food aid, 
considering alternate processing methods that improve nutritional efficacy, and improving the 
programming of food aid delivery and acceptability (35). To improve the macronutrient content, 
it was suggested that whey protein concentrate (WPC) be added to increase protein quality, and 
the fat content be increased by preparing CSB with fortified vegetable oil, thereby increasing the 
overall energy content (35). To address micronutrient content improvements, recommendations 
were made to reformulate certain levels of vitamins and minerals, including combining two 
forms of iron, NaFeEDTA and ferrous fumarate, to improve iron absorption (35), which is of 
particular interest. Sorghum was recommended as an alternative cereal to develop new cereal-
based FBFs due to its “acceptability in Africa, its relatively low price, and its acceptability 
among host governments”, as well as being used in combination with other pulses to produce a 
sorghum-pea blend, for example (35). Collaboration with industry to utilize different processing 
methods, such as extrusion, could improve FBF shelf life, nutrient availability and quality (35). 
CSB14 was introduced in this report to replace CSB13 as a model FBF that would meet the 
recommended improvements (35).  
 Commodities 
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 Sorghum 
Sorghum is the fifth most produced cereal globally (36), and the second most important 
cereal in Africa (37). The US is largest producer, however 90 percent of the world’s sorghum 
area is in Africa and Asia (36). Sorghum, along with millet, provides energy to more than 300 
million people in developing countries as part of their staple diet (37). Sorghum is drought-
tolerant, and has been shown to have less dryland yield variation and sensitivity to environmental 
conditions compared to corn (38). It is widely accepted by most food aid receiving countries due 
to its typically cheaper price compared to corn, and it is not genetically modified which is 
desirable to many countries (38). Sorghum is primarily used for food in porridges, breads, and 
beverages, however in some countries it is mainly used for animal feed (36). The nutrient 
composition of sorghum is similar to corn (38), and could therefore be a feasible option to 
replace it in FBFs. Sorghum has also been proposed as a functional ingredient due to its ability to 
manage glucose and insulin levels in healthy adults (37).  
 Cowpea 
Cowpeas, or black-eyed peas, are a grain legume primarily produced and consumed in 
Africa (63%) (39). Cowpea is drought-tolerant, and rich in protein (23-32%) and lysine (427 
mg/g N) to complement sorghum or corn in a FBF (40).Compared to soy, cowpea contains lower 
total protein and fat content, but higher starch content (41). Cowpea can be intercropped with 
sorghum, and improves soil fertility and cropping systems through nitrogen fixation and its deep 
roots, which preserve moisture and stabilize soil (42).  
 Antinutritional factors 
Antinutritional factors occur naturally in foods or are formed through protein processing, 
and are known for reducing protein digestibility, amino acid bioavailability and thus overall 
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protein quality of foods, as well as decreasing mineral bioavailability (43). In developing 
countries where there are less refined foods, antinutritional factors play an important challenge in 
improving macro and micronutrient availability from foods (43). Trypsin inhibitors, 
hemagglutinins, tannins, phytates, glucosinolates, gossypol, and uricogenic nucleobases are 
naturally occurring in legumes, cereals, oilseeds and certain protein products (43). Malliard 
reaction products, oxidized sulphur amino acids, D-amino acids, and lysinoalanine are formed 
during heat or alkaline treatments of protein products (43). Tannins and phytates are of particular 
interest due to their occurrence in potential FBF commodities, sorghum and cowpea. Sorghum 
and cowpea contain 0.5-72.0 and 1.4-10.2 g/kg tannin, respectively (43).  Tannins in sorghum 
have been cited to decrease protein and amino acid digestibility by up to 23% in rats, pigs, and 
poultry (43). Sorghum also contains phytates (7 g/kg), which is comparable to corn, however 
cowpeas contain no phytates, which is a potential advantage for replacing it over soybean (26 
g/kg) in FBFs (43). Phytates in foods have been cited to reduce protein and amino acid 
digestibility by up to 10% (43). Despite these disadvantages, tannins and phytates may have 
antioxidant, cancer fighting, and cardiovascular health benefits (44). 
 Extrusion processing 
Extrusion processing involves moisture, pressure, high temperature, and mechanical 
shear applied to pre-conditioned starchy or proteinacious food to quickly cook and expand it 
through a die (45). This results in desirable enzyme denaturation, antinutritional factor (trypsin 
inhibitors, hemagglutinins, tannins, phytates) inactivation, final product sterilization, while 
retaining food color and flavor (45). It also increases protein digestibility, which is an important 
protein quality determinant especially in FBFs, with increasing extrusion temperature and animal 
protein feed ratio due to protein denaturation and inactivation of enzyme inhibitors, thereby 
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allowing increased digestive enzyme activity that results in improved protein bioavailability (45). 
Extruded products are also considered “precooked”, and therefore don’t take as much time or 
resources to prepare compared to traditional raw foods, which is desirable for improving FBFs. 
One potential drawback to extrusion processing is the retention of lysine, an essential and most 
limiting amino acid in cereal products, however increasing screw speed and reducing die 
diameter has been reported to enhance retention (45). Iron content of extrudates is usually 
increased due to metallic wear from the extruder screws (45). Collectively, mild extrusion 
conditions (high moisture content, low residence time, low temperature) results in higher amino 
acid retention, protein and starch digestibility, soluble dietary fiber, vitamin retention and 
mineral absorption, as well as decreased lipid oxidation (45).  
 Extrusion processing effects on protein digestibility and iron absorption 
In general, protein digestibility is reported to improve due to extrusion processing, 
however decreasing available lysine content may be a concern. In one study with broiler 
chickens fed extruded versus non-extruded soybean meal, extruded soybean meal resulted in 
increased crude protein and amino acid digestibility, daily feed intake, average daily weight gain, 
and feed conversion ratio, suggesting extrusion improves nutritive value for broiler chicks (46). 
Feed moisture, screw speed, and barrel temperature had a linear effect on maize-mungbean 
extrudates for preferable functional properties including specific mechanical energy, bulk 
density, water absorption index, water solubility index, and degree of gelatinization, indicating 
locally available, affordable ingredients in low-income countries could use extrusion technology 
to produce nutritious weaning foods (47). In another study, the combination of micronized 
cowpea with extruded sorghum flour in a ready-to-eat porridge provided 40% of children’s 
protein and lysine requirements, comparable to commercial maize-soy instant products 
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suggesting it could be used as a replacement (48). In extruded cassava-soy complementary 
porridge, the PDCAAS increased by 35 and 67% (with defatted or full fat soy), however 
available lysine was decreased in the extruded porridges by 12.5 and 16.7% compared to the 
same conventionally-cooked porridges (49). Extrusion processing increased in vitro protein 
digestibility in corn and lima bean flour blends (82%) compared to the raw flours (77%) (50). In 
extruded vs raw peas fed to rats, most amino acids were not affected by extrusion (including 
lysine), iron content was increased due to extruder screw wear (27%), and antinutritional factors 
were reduced by 5.9 to 98.3% (51). In vitro protein digestibility was significantly increased 
(4%), and when supplemented with required amino acids, rats fed extruded pea diet gained more 
weight and had higher PERs compared to rats fed raw pea diet (51). When whole grain red 
sorghum was extruded, protein digestibility increased 31% measured by an in vitro method, 
however available lysine was reduced by 25.4%; iron bioavailability was not affected (52).  
Extrusion processing effects on iron bioavailability from foods are not as clear. In normal 
adults consuming either extruded or nonextruded wheat bran-flour in two separate test meals 2 
weeks apart, no significant difference in iron retention was found after measuring iron absorption 
from meals (53). In 39 normal adults, four different cereal porridges (rice, maize, high extraction 
wheat, and low extraction wheat flours) produced by three different industrial processing 
methods (extrusion, roller-dried with sucrose, roller-dried without sucrose) were home-cooked 
and consumed and iron absorption was measured by Fe extrinsic tag technique; the type of 
industrial processing had no significant effect on iron absorption (54). In ileostomy subjects, 
mild extruded bran product consumption for two 4 day periods did not impact iron absorption 
compared to the corresponding non-extruded version when ileostomy contents were analyzed 
(55). 
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 Chicken Model 
 Background 
Rat and pig based models have traditionally been used as iron models to determine how 
iron outcomes could be expected to be impacted in humans. It has been suggested that the rat 
model for iron bioavailability may not be ideal because of some distinct physiological 
differences (56), and that the broiler chicken (Gallus gallus domesticus) might be a better in vivo 
model for assessing iron bioavailability from foods (57). It would be ideal to find a model that 
can accurately assess for iron absorption and protein quality; iron deficiency and PEM 
commonly co-occur, both have high prevalence rates (58). An accurate model may allow for 
better nutrition facilitation for food aid products, however, it is not clear whether the chicken 
model could be used for protein-quality assessment. 
 Methods for evaluating iron bioavailability 
The primary methods for assessing iron bioavailability include radioiron or stable iron 
isotopes and postabsorption plasma iron measurements (59), the in vitro digestion/Caco-2 cell 
model (60), and the animal hemoglobin depletion-repletion bioassay (59). Radioiron methods 
measure the amount of radioiron incorporated into red blood cells, and the difference between 
ingested and excreted radioiron from urine or feces to estimate absorption (59). Postabsorption 
plasma iron measures increases in plasma iron after oral iron administration (59). The advantage 
of these is that they can directly measure human iron bioavailability, however often times they 
are not feasible due to their time-intensive nature, cost, and radiation exposure (59).  
For these reasons and more, non-human iron bioavailability studies are important and 
necessary due to their feasibility and cost-effectiveness. In vitro, Caco-2 cells differentiate and 
exhibit enterocyte-like features such as brush border microvilli and enzyme formation, and 
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increased uptake of ferrous rather than ferric iron (59, 60). Thus, the in vitro digestion/Caco-2 
cell model is commonly used to simulate digestion and assess acute iron availability from foods 
by measuring ferritin formation (60). However, there are still important limitations to consider 
when extrapolating data from in vitro to in vivo human applications, such as limited 
gastrointestinal environment conditions, difficulty reproducing results, and inconsistent 
correlations to human outcomes that require confirmation (61). 
Variations of the animal hemoglobin depletion-repletion model have been used to assess 
iron bioavailability. Usually, animals are fed an iron-deficient diet to develop anemia, then diets 
with the iron compound of interest are consumed to measure hemoglobin repletion relative to a 
reference source of iron (59). Rats have largely been used for this model, however pigs and 
chickens have also been used to mimic iron bioavailability in vivo (56, 62). Rats have been cited 
to absorb iron highly similar to humans (63), however this may be exaggerated due to large 
differences in energy expenditure for body size, lifespan, body proportion, and gastrointestinal 
morphology (56, 64). Pigs are more similar to humans in these aspects (56), however they are 
also more costly. More recently, chickens have been cited multiple times to respond as expected 
to dietary iron, and agree well with the in vitro digestion/Caco-2 cell model (57), and are more 
cost effective compared to rats and pigs. 
 Methods for evaluating protein quality 
Some factors that influence protein quality assay procedure results include age and sex of 
animal, body weight, protein quantity and quality, food intake, other dietary components, 
husbandry, and environmental conditions (65). 
Animal models primarily use a modified protein efficiency ratio (PER) to evaluate 
protein quality. Biological value (BV), net protein utilization (NPU), net protein ratio (NPR), 
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slope assay procedure, relative nitrogen utilization (RNU), and relative protein value (RPV) have 
also been proposed protein assays in rats (65). However due to intensive labor including urine 
and fecal sample collection, difficult measurements such as carcass nitrogen, preference against 
non-protein diet feeding, and overestimation of certain amino acid-deficient proteins, most of 
these assays are not feasible or routine (65). Ideal standard proteins for growth and maintenance 
that are similar to protein needs for humans are needed, but since this is not possible, selections 
must be made by test simplicity, economics, labor, and reproducibility (65). 
In rats, the PER method has been commonly used for determining dietary protein quality 
(66). The PER assay is simply weight gain (g) divided by protein consumption (g) usually 
measured over a 28 day period (65). PER assays are effective and feasible due to their short-time 
period and low cost (65). A PER assay has been outlined in chickens using the same calculation, 
however only 14 days are needed to assess protein quality (67). The PER assay does have some 
limitations, including it not accounting for maintenance or potential complementary effects of 
two or more proteins during mixed feeding, however this is common among other bioassay 
procedures as well (65).  
 Gastrointestinal anatomy and physiology comparison between common models 
 Rat model 
Animal gastrointestinal tract (GIT) anatomy is a main focus when considering feasibility 
of an animal model for human nutrition research. Rats are most similar to humans in their GIT 
morphology, however their main differences occur in their GIT gross anatomy and environment 
(68) due to their different life span, body size and proportion, which causes significant 
differences in food intake and energy expenditure (56).  
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Rodents have a less glandular stomach compared to humans (entire stomach is secretory), 
chickens, and pigs (69), and consists of two distinct regions separated by a limiting ridge that 
prevents the rat from retching (68). In humans, the small intestine contains watery chyme and 
folds in the luminal epithelium (plicae circulares); rats, do not have these folds (reducing surface 
area by 200-fold), their chyme is thick and chalky (68). Data normalized for body weight is an 
accurate correction when using rat models, where the relative gut surface area is four times less 
than in humans (68). The small intestine of humans, rats, pigs, and chickens is similarly divided 
into the duodenum, jejunum, and ileum and contain millions of villi designed to increase gut 
surface area and aid in nutrient absorption (56, 68-70), however in rats the jejunum makes up 
90% of their small intestine compared to 38% in humans (68). Humans total intestinal length is 
4.0-6.85 times longer compared to rats (calculated from Table 1.1). The rat cecum is large 
compared to the human cecum, which is poorly defined and continuous with the colon (69). In 
rats, the colon is not sacculated or long as compared to humans and pigs, and does not contain a 
sigmoid colon (69). The bile flow (mL bile per kg body weight each day) in rats is 2 to 42 times 
higher than that of humans since it is secreted continuously from the liver due to their lack of a 
gallbladder (69). Rats have higher GIT water content (7.8 fed, 3.2 mL fasted) compared to mice 
(0.98 fed, 0.81 mL fasted), and when normalized for body weight both have more water per kg 
body weight in GIT compared to humans which can especially affect drug dissolution and 
dispersion (71). In rats, intestinal pH levels have been reported to be lower than in humans, 
which can affect nutrient solubility and absorption (71). Throughout the small and large 
intestine, rats and mice have similar bacterial counts as compared to humans (69), however rats 
contain microorganisms in their stomach as well (68). Rats also practice coprophagy, which is 
important to note (56). Collectively, these differences may suggest that the human GIT can 
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absorb a higher volume of materials, and absorb them more quickly compared to rats (68), which 
is important to consider when extrapolating data between models. 
 Pig model 
Primary similarities between pigs and humans are their digestion physiology, metabolic 
processes, nutritional requirements, transit time (56), and body size and proportion compared to 
rats or chickens, however there are still a few differences in pigs to take into consideration. The 
stomach of pigs is 2 to 3 times larger than that of humans, and they have a greater cardiac 
mucosa region that secretes mucus (69). The pigs stomach capacity (L) is 3.75 to 8 times larger 
than that of humans (69). Another distinct difference between the pig and human GIT is its 
spatial arrangement (56). In humans, the small intestine sits behind the large intestine, but in pigs 
it is on the right side of the abdomen (56). The large intestine in humans is more square-like, 
whereas in pigs it is in a spiral conformation (56). The total intestinal length of pigs is much 
longer than humans (2.2-4 times), therefore its intestinal weight is also (2.5 times), however 
when intestinal length is normalized to per kg bodyweight, they are similar (Table 1.1) (56). 
Differences in body fat percent and distribution may have different effects on iron regulation due 
to increased hepcidin levels seen in severely obese humans (56). Pigs also practice coprophagy, 
but not as frequently as rats (56). Compared to rats, pigs generally have more acidic pH values, 
but these values are comparable along the entire gastrointestinal tract (69). Pigs generally have 
more bacterial organisms per gram content of the GIT compared to rats, except for yeasts which 
occur in higher amounts overall in the GIT of rats (69).  
 Chicken model 
A few of the main differences between avian and mammalian digestive systems are the 
former’s modifications to aid flight, shortened intestinal tract, and lack of teeth and heavy jaw 
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muscles (70). Birds swallow their food whole, and the particles are later reduced by the 
ventriculus (gizzard; 70). Their sphincter-lacking esophagus transports food from the pharynx to 
the stomach, during this process, food can be stored in their crop, located in the cervical 
esophagus (70). Although birds are considered to be monogastrics, the proventriculus, along with 
the gizzard, act as a two chambered stomach in birds (70). The proventriculus is most identical to 
the mammalian stomach in that it is glandular; secrets mucus, hydrochloric acid, and pepsinogen, 
while the gizzard acts as the muscular stomach and mechanically digests food (70). Chickens 
contain paired ceca, which are unique to this model, that aid in additional small particle and fluid 
absorption (70). The ceca are thought to contain 87-97% urine since birds lack a urinary bladder 
(70). The chicken colon is mainly involved in water reabsorption, but has flat villi and few goblet 
cells relative to mammals (70). In chickens, digestive, excretory and reproductive waste is 
excreted through the cloaca, which is not present in mammals (70). Total rate of passage through 
the GIT varies due to diet and size of the animal. In chickens, the GIT can have a mean retention 
time of 5-9 hours when measured with insoluble markers (70), however in humans it is around 
20 – 30 hours, which is most similar to pigs (69). The total intestinal length of humans is 3.6-4.4 
timers longer compared to chickens (calculated from Table 1.1). Providing microbes in feed for 
poultry has been an accepted strategy to improve health, productivity, and weight gain (70), and 
therefore should be taken into consideration as well among models. Total lipid to protein ratios 
are similar in the chick, pigs, rat and mouse (0.5-0.6), which can affect fluidity of the membrane 
and thus absorption (69). 
Table 1.1 Comparison of characteristics between models   
Characteristics Human1 Chicken2 Pig1 Rat3 
Average mature 
weight (kg) 
60 - 100 3.0 200 - 300 0.254 
Body length 1.8 0.46 1.25 0.17 
19 
(m)5 
Small intestinal 
length (m) 
5.50 - 7.0 1.8 15 - 22 1.0 – 1.5 
Large intestinal 
length (m) 
1.5 0.13 4 - 6 0.2 – 0.3 
Total intestinal 
length (m) 
7 – 8.5 1.9 19 - 28 1.2 – 1.8 
Total intestinal 
length for body 
length (m/m) 
3.9 – 4.7 4.1 15.2 – 22.4 7.1 – 10.6 
Small intestinal 
weight (g) 
1040 73.6 2310 ND 
Large intestinal 
weight (g) 
590 5.1 1970 ND 
Total intestinal 
weight for body 
weight (g/kg) 
16.3 – 27.2 0.03 14.3 – 21.4 ND 
Gastric pH 1.0 – 2.5; up to 5 
(fed)9 
4.658 4.47 3.2 – 3.96 
Small intestinal 
pH 
6.2 – 7.99 6.0 – 6.48 6.1 – 6.77 6.66 
GIT water 
content (mL) 
35 ± 710 ND 1546 (g)7 3.2 – 7.86 
Normal 
hemoglobin 
concentration 
(g/dL) 
14 – 18 
(males)12 
10.115 > 11.013 11.0 – 19.214 
Normal hepatic 
iron content 
(µg/g) 
2.011 5516 ND ND 
ND: No data. 
Adapted from 1(56), 2(70), 3(69), 4(68), 5(72), 6(71), 7(73), 8(74), 9(75), 10(76), 11(77), 12(78), 
13(79), 14(80), 15(81), 16Averaged values from standard iron diets reported in Tako et al. 2016 
(64). 
 
 Current applications of the chicken model for human nutrition research 
 Iron bioavailability studies 
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Iron bioavailability of foods using the broiler chicken (Gallus gallus) model has been 
determined to assess single meal iron availability using a duodenal loop preparation and the 
stable isotope 58Fe, as well as longer term iron availability from feeding trials; both have been 
shown to exhibit the appropriate response to dietary iron (57). Since 2010, ten primary research 
studies using the broiler chicken model to predict iron availability from foods have demonstrated 
that chickens respond appropriately to dietary iron levels by Hb concentration, total body Hb Fe, 
Hb maintenance efficiency (HME), liver ferritin and iron, and duodenal expression of proteins 
involved in iron reduction, uptake, and transport (DcytB, DMT-1, and ferroportin, respectively; 
(57, 62, 82-85, 85-87). This model has also been shown to mimic ferritin outcomes of in vitro 
digestion with the Caco-2 cell model (57, 62, 82-85, 85-87). However, it is worth noting that 
after normalizing data to the low iron diets in studies with similar diet formulations, the Caco-2 
cell model exaggerated iron absorption between different dietary levels of iron as compared to 
other outcomes with chickens or pigs (82, 88, 89). Collectively, results show that chickens fed 
higher iron diets had increased or improved iron outcomes compared to chickens fed lower iron 
diets (57, 82, 83, 85-87, 90; Table 1.2). This is significant in that it supports the chicken model 
being sensitive to dietary iron levels and therefore exhibiting the appropriate response (57). 
These results also collectively agreed well with the in vitro digestion/Caco-2 cell model for 
ferritin formation (57, 82, 83, 85-87, 90). In vivo observations were made in two studies, and 
chickens agreed most with rats for certain iron outcomes such as liver ferritin and iron, and 
intestinal iron (91), exhibiting appropriate and similar responses to dietary iron compared to a 
well-known in vivo model, which is important for extrapolating data between in vivo models. In 
a recent review, two out of three feeding trials of standard or biofortified iron beans in chickens 
demonstrated nutritional benefit, which agreed with corresponding human efficacy studies fed 
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the same type of diet (64). Previously, the chicken model has been limited to agreement of 
response to dietary iron only in vitro, however this finding enhances its usefulness for 
extrapolating iron outcomes to humans (64). In conclusion, the broiler chicken model offers a 
rapid and cost-effective in vivo assessment of long term iron bioavailability from foods that can 
serve as a useful intermediary step to confirm in vitro results and advance experimental 
objectives to human efficacy studies (64).  
Table 1.2 Summary of iron bioavailability studies performed using the chicken model for 
nutritional research 
Reference Models N 
Study 
Length 
(Days) 
Intervention Outcome 
Comparison 
to chicken 
model 
(91) Rat, broiler 
chicken, 
Indian hill 
and 
common 
mynahs, 
turtledove 
8 Not 
reported 
Basal diet with 60-90 
µg/g iron to evaluate 
intestinal and liver 
ferritin 
1) Rats (control) 
2) Chickens 
3) Turtledoves  
4) Indian hill mynahs  
5) Common mynahs 
Liver ferritin (µg/g wet 
wt.): 
1) 969, 2) 914, 3) 634, 4) 
1207, 5) 346 
Liver ferritin saturation 
(%): 
1) 12, 2) 11, 3) 9, 4) 28, 
5) 34 
Liver iron (µg Fe/g wet 
weight): 
1) 63, 2) 52, 3) 31, 4) 
179, 5) 78 
Liver iron (µmol Fe/µmol 
ferritin): 
1) 550, 2) 515, 3) 423, 4) 
1252, 5) 1541 
Intestinal ferritin (µg/g 
wet wt.): 
1) 73, 2) 443, 3) 98, 4) 
116, 5) 57 
Intestinal ferritin 
saturation (%): 
1) 13, 2) 14, 3) 9, 4) 31, 
5) 21 
Intestinal iron (µg Fe/g 
wet weight): 
1) 5, 2) 34, 3) 5, 4) 20, 5) 
6 
Intestinal iron (µmol 
Fe/µmol ferritin):  
1) 567, 2) 616, 3) 412, 4) 
In vivo 
22 
1401, 5) 958 
(92) Broiler 
chicken, 
rat, dog, 
cat 
20 14 Casein-dextrose 
based diet with 
graded levels of 
ferrous sulfate as 
hemin or 
hemoglobin iron, 
compared among rat, 
chick, dog, and cat. 
Hemoglobin iron 
bioavailability was 
highest in chicks (93%) 
compared to rats (68%), 
dogs (90%) and cats 
(70%), while hemin was 
poorly available to rats 
and completely 
unavailable among other 
models. 
In vivo 
(83) Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
12 28 Corn and biofortified 
or standard red 
mottled bean diets 
with low or high Fe: 
1. High-Fe (54) 
2. Low-Fe (42) 
(Fe content in µg/g) 
In vivo (day 28): 
Body weight (g): 
1) 684.3, 2) 599.9 
Hb concentration (g/L): 
1) 75.5, 2) 73.71 
Total body Hb-Fe (mg): 
1) 15.04, 2) 12.58 
HME (%): 
1) 15.9, 2) 17.6 
Fe protein gene 
expression: 
1) slightly lower than 2)  
Ferritin μg/g wet weight: 
1) 425, 2) 409 
Iron μg/g wet weight: 
1) 48.1, 2) 39.5 
Iron/ferritin μmol: 
1) 68.5, 2) 59.8 
In vitro: 
Ferritin (ng/mg of 
protein): 
1) 15.7, 2) 11.2 
In vitro 
(90)# Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
10 42 High and low-Fe 
bioavailability maize 
based diets with or 
without added Fe: 
1. High + Fe (65)* 
2. High (24) 
3. Low + Fe (66)* 
4. Low (23) 
(Fe content in µg/g) 
*supplemented as 
ferric citrate 
In vivo (day 42): 
Body weight (g): 
No significant differences 
Hb concentration (g/L): 
1) 97, 2) 82, 3) 87, 4) 67 
Total body Hb-Fe (mg): 
1) 16.49, 2) 13.79, 3) 
14.52, 4) 10.73 
HME (%): 
1) 20.2, 2) 44.9, 3) 13.8, 
4) 35.8 
Fe protein gene 
expression: 
In vitro 
23 
1) < 3) < 2) < 4) 
Ferritin μg/g wet weight: 
1) 650, 2) 435, 3) 645, 4) 
355 
Iron μg/g tissue: 
1) 64.3, 2) 52.2, 3) 39.6, 
4) 43.3 
In vitro: 
Ferritin (ng/mg of 
protein): 
1) 74.36, 2) 6.55, 3) 
56.89, 4) 1.31 
Fe concentration (µg/g 
sample): 
1) 65.3, 2) 24.5, 3) 66.1, 
4) 23.6 
(85) Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
14 42 Corn and biofortified 
or standard Fe black 
bean diet: 
1. Standard (39) 
2. Biofortified (52) 
(Fe content in µg/g) 
In vivo (day 42): 
aHb concentration (g/L): 
1) 68, 2) 78 
aTotal body Hb-Fe (mg): 
1) 24.5, 2) 27 
aHME (%): 
1) 18, 2) 15 
Fe protein gene 
expression: 
1) = 2) 
Ferritin μg/g wet weight: 
1) 282, 2) 293 
Iron μg/g wet weight: 
1) 27.2, 2) 33.1 
Iron/Ferritin (μmol) 
1) 39.8, 2) 45.6 
In vitro: 
Ferritin (ng/mg of 
protein): 
1) 2.97, 2) 2.75  
In vitro 
(86) Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
12 42 Biofortified or 
standard pearl millet 
based diets: 
1. High-Fe (78) 
2. Low-Fe (22) 
(Fe content in µg/g) 
In vivo (day 42): 
Body weight (g): 
From day 14, 1) > 2) 
aHb concentration (g/L): 
1) 75, 2) 70 
Total body Hb-Fe (mg): 
1) 25.6, 2) 14.4 
aHME (%): 
1) 13, 2) 57 
Fe protein gene 
In vitro 
24 
expression: 
1) < 2) 
Ferritin μg/g wet weight: 
1) 285, 2) 277 
Iron μg/g wet weight: 
1) 25.2, 2) 19.3 
Iron/Ferritin (μmol) 
1) 34.5, 2) 29.7 
In vitro: 
Ferritin (ng/mg of 
protein): 
1) 2.46, 2) 1.47 
(87) Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
14 42 Biofortified or 
standard cream 
seeded carioca bean 
based diets: 
1. Biofortified (48) 
2. Standard (33) 
(Fe content in µg/g) 
In vivo (day 42): 
Body weight (g): 
From day 21, 1) > 2) 
aHb concentration (g/L): 
1) 85, 2) 81 
aTotal body Hb-Fe (mg): 
1) 30.5, 2) 25 
aHME (%): 
1) 17, 2) 20 
Fe protein gene 
expression: 
DMT-1: 1) < 2); others: 
1) = 2) 
Ferritin μg/g wet weight: 
1) 315, 2) 284 
Iron μg/g wet weight: 
1) 62.6, 2) 45.5 
In vitro: 
Ferritin (ng/mg of 
protein): 
1) 2.73, 2) 1.96 
In vitro 
(57) Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
10 42 
(start at 
7 d, 49 
total) 
Corn-soy diet with 
adequate or deficient 
Fe content:  
1) High-Fe (141)* 
2) Low-Fe (51) 
(Fe content in µg/g) 
*supplemented as 
ferric citrate 
 
In vivo (day 49): 
Body weight (g): 
1) 2828, 2) 2647 
Hb concentration (g/L): 
1) 107, 2) 72 
Total body Hb-Fe (mg): 
1) 85, 2) 54 
HME (%): 
1) 11.8, 2) 21.9 
Fe protein gene 
expression: 
1) lower, 2) higher 
In vitro 
25 
Fe absorption: 
1) 13.35, 2) 22.11 
In vitro: 
Ferritin formation (ng 
ferritin/mg protein): 
1) 14.78, 2) 5.18 
(82) Broiler 
chicken, in 
vitro 
digestion/ 
Caco-2 
cell culture 
model 
6 49 
(start at 
7 d, 56 
total) 
Corn and white or 
red bean based diets 
with low or high Fe:  
1) WB+Fe (179)* 
2) WB (51) 
3) RB+Fe (175)* 
4) RB (47) 
(Fe content in µg/g) 
*supplemented as 
ferric citrate 
In vivo (day 56): 
Body weight (g): 
1) 3143, 2) 2859, 3) 
2936, 4) 2649 
Total body Hb-Fe (mg): 
1) 84.1, 2) 74.4, 3) 73.5, 
4) 61.0 
HME (%): 
1) 7.8, 2) 19.5, 3) 6.3, 4) 
17.5 
Fe protein gene 
expression: 
1) < 2) < 3) < 4)  
Ferritin μg/g wet weight: 
1) 1003, 2) 708, 3) 572, 
4) 371 
Iron μg/g wet weight: 
1) 64.7, 2) 53.5, 3) 35.2, 
4) 24.1 
Iron/ferritin μmol: 
1) 99.8, 2) 76.6, 3) 57.4, 
4) 43.2 
Liver ferritin iron 
saturation (%): 
1) 16, 2) 14.5, 3) 11, 4) 9 
In vitro: 
Ferritin (ng/mg of 
protein): 
1) 71.84, 2) 11.84, 3) 
51.78, 4) 2.97 
In vitro 
aValues estimated from graphs. #Article was retracted due to maize lines not being isogenic as portrayed, however 
data pertaining to available iron levels in maize lines are correct, and the in vitro and in vivo methods are valid and 
legitimate, and therefore the data cited is still correct and relevant for the purpose of this paper. 
Note:  For all Tako et al. studies, Fe: iron, Hb: Hemoglobin, HME: Hemoglobin maintenance efficiency calculated 
as =  
𝐻𝑏 𝐹𝑒 (𝑓𝑖𝑛𝑎𝑙)−𝐻𝑏 𝐹𝑒 (𝑖𝑛𝑖𝑡𝑖𝑎𝑙)
𝑇𝑜𝑡𝑎𝑙 𝐹𝑒 𝐼𝑛𝑡𝑎𝑘𝑒 (𝑚𝑔)
𝑥 100, (88, 93), where Hb Fe = total body Hb Fe calculated as =
 𝐵𝑊 (𝑘𝑔)𝑥 0.085 𝐿
𝑏𝑙𝑜𝑜𝑑
𝑘𝑔
𝑥 𝐻𝑏 (
𝑔
𝐿
𝑏𝑙𝑜𝑜𝑑) 𝑥 3.35 
𝑚𝑔 𝐹𝑒
𝑔 𝐻𝑏
.  “Fe protein gene expression” includes DMT-1: divalent 
metal transporter 1 (Fe uptake transporter), DcytB: duodenal cytochrome B (reduces Fe at brush border), and 
ferroportin (Fe transport across enterocyte). Fe absorption: estimated from concentrations of stable isotope tracer 
(58Fe) in whole blood relative to 56Fe natural abundance concentration (57).  
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 Limitations of the chicken model 
Although the chicken model is useful for assessing iron bioavailability from foods due to 
its anatomy, size, growth rate, and low cost (57), it does have some noteworthy limitations. Up to 
date, the chicken model’s response to dietary iron has primarily been studied directly with the in 
vitro digestion/Caco-2 cell model and therefore is limited in this aspect (57, 62, 82-85, 85-87). 
While this in vitro model has been shown to be useful for this application, it is still difficult to 
extrapolate this data to humans. Another limitation of the chicken model is their susceptibility to 
leg disorders, such as tibial dyschondroplasia, resulting in gait issues, which affects their eating 
patterns and thus weight gain due to decreases in locomotion (94, 95). Broiler chickens also have 
a higher mortality rate (4.8%) (96), compared to that usually found with rats or pigs, however in 
some studies preweaning mortality has been found to be higher in mice (5-20%) and swine (7-
20%) (97).  
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Chapter 2 - Assessment of iron bioavailability and protein quality of 
new fortified blended foods in broiler chickens 
 Abstract 
Iron deficiency and protein-energy malnutrition commonly co-occur in food aid receiving 
countries. Corn and soybean based fortified blended foods (FBFs) have been the primary food 
aid product provided by the United States to address these conditions. Sorghum and cowpea have 
been suggested as alternative FBF commodities because they are drought-tolerant, are grown in 
food aid receiving areas, and are not genetically modified. Extrusion processing has also been 
suggested to improve the quality of these FBFs. The primary objective of these studies was to 
determine protein quality and iron bioavailability of newly formulated sorghum, cowpea, soy, 
and corn-based FBFs, compared with the current USAID corn and soy blend FBF, CSB+, in 
broiler chickens, which have been suggested to be a good model for iron bioavailability. Two 
secondary objectives were to compare the protein quality of whey protein concentrate (WPC) to 
soy protein isolate (SPI) in FBFs, and to determine if reformulation and over-processing of FBFs 
could be equally efficacious, less expensive FBF options. 
New FBFs consisted of extruded corn-soy (CSB14), white sorghum-soy (WSS), and 
white sorghum-cowpea (WSC); all containing WPC. Another extruded white sorghum-cowpea 
FBF (WSC+SPI) was similarly produced, but contained SPI rather than WPC. Additionally, two 
reformulated, over-processed white sorghum-cowpea FBFs (one with WPC: O-WSC, one with 
SPI: O-WSC+SPI), and a non-extruded sorghum-cowpea FBF (N-WSC) containing WPC were 
produced. Two studies were performed using prepared (Prep) or dry (Dry) versions of new FBFs, 
along with CSB+ and a control chicken diet. In the Prep study, nine groups of 8-day old broiler 
chicks (n = 10) consumed treatment diets for 21 days. In the Dry study, eight groups of 4-day old 
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broiler chicks (n = 24, control n = 23) consumed treatment diets for 14 days. Results were 
analyzed by one-way ANOVA with LSD test using SAS Studio 3.6. 
In the Prep study, new FBFs significantly increased caloric and protein efficiency, and 
nonsignificantly increased body weight gained compared to CSB+, despite similar food intake. 
In the Dry study, CSB+ significantly decreased food intake and caloric efficiency, with the 
exception of O-WSC+SPI, and nonsignificantly reduced body weight gain and protein efficiency 
compared to new FBFs. CSB+ significantly and nonsignificantly reduced hepatic iron content 
compared to all FBFs in the Dry and Prep studies, respectively. 
In conclusion, new FBFs, with the exception of O-WSC+SPI, resulted in improved food 
efficiency and hepatic iron outcomes compared to CSB+, suggesting they are of higher 
nutritional quality; sorghum and cowpea are suitable replacements for corn and soy, SPI is a 
viable alternative to WPC, and reformulated, over-processed WSC with WPC can be considered 
as a less expensive FBF option. However, further research is needed to refine and identify the 
best FBF formulations. 
 Background 
Protein-energy malnutrition and iron deficiency continue to be the most common 
nutritional deficiencies globally (2, 15, 16). Fortified blended foods (FBFs), partially precooked 
grain-legume blends that are micronutrient fortified, have traditionally been used to treat these 
conditions (31), however they have not been consistently effective. The current most commonly 
used United States Agency for International Development (USAID) FBF is corn-soy blend plus 
(CSB+) (33). Recommendations have been made to improve FBFs, including utilization of 
different commodities that are drought-tolerant and locally available in food aid receiving 
countries, as well as using processing methods such as extrusion to improve nutritional quality of 
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FBFs (35). Sorghum and cowpea are suitable replacements for corn and soy in FBFs primarily 
due to their complementary amino acids (40), and high availability and consumption in food aid 
receiving countries (36, 39), which can promote local and regional procurement and thus 
improve agricultural market and nutritional outcomes in these areas (35). Extrusion processing, 
which involves moisture, high pressure, temperature, and mechanical shear to quickly cook food, 
has been shown to decrease antinutritional factors and thus improve protein and iron 
bioavailability from FBFs (45). This process also precooks the FBFs, requiring less time and 
resources to prepare which is beneficial in these areas. It has also been suggested that an animal 
source protein, such as whey protein concentrate (WPC), be included in FBFs to improve 
protein-energy malnutrition, such as stunting and wasting (35), however its costly inclusion has 
not been entirely supported or justified (10, 11). Plant protein, such as soy protein isolate (SPI), 
may be a less expensive option for inclusion in FBFs to obtain similar nutritional outcomes (12). 
The chicken model has been suggested to be a good in vivo model for assessing iron 
bioavailability because its iron outcomes are consistent with the widely used in vitro 
digestion/Caco-2 cell model (57). It has also shown sensitivity to long term dietary iron levels by 
exhibiting expected responses to high and low iron diets (57). Rats have traditionally been the 
primary in vivo model for this application, and pigs have been common too, however due to the 
former’s more efficient iron absorption due to large differences in energy expenditure for body 
size, lifespan, body proportion, and gastrointestinal morphology, and the latter being more costly 
(56), the chicken model becomes more useful due to its anatomy, size, growth rate, and low cost 
(57). However, its viability as an in vivo model for assessing iron bioavailability has been limited 
to mirroring this outcome only in vitro, and to the best of our knowledge, while a PER model has 
been established (67), the chicken model has not been used to assess protein quality of foods for 
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a human nutrition application. In a recent review two out of three feeding trials of standard or 
biofortified iron beans in chickens demonstrated nutritional benefit, which agreed with 
corresponding human efficacy studies with similar diets (64). Although this extrapolation is still 
limited, this further supports the application of the broiler chicken model; it ultimately offers a 
rapid and cost-effective in vivo assessment of long term iron bioavailability from foods that can 
serve as a useful intermediary step to confirm in vitro results and advance experimental 
objectives to human efficacy studies (64). 
The primary objective of the two studies outlined in this paper was to determine the 
protein quality and iron bioavailability of new FBFs compared to a current USAID FBF, CSB+. 
Extruded sorghum, cowpea, corn, and soy FBFs were formulated according to USAID 
recommendations (35) along with a non-extruded sorghum-cowpea group to assess if sorghum 
and cowpea can be used as alternative commodities to corn and soy, and if extrusion processing 
is needed to result in similar or improved protein and iron outcomes. Another objective was to 
compare the protein quality of WPC to SPI inclusion in FBFs. Additionally, two reformulated, 
over-processed less expensive FBFs were developed to determine if this formulation can be a 
more cost-effective option to obtain similar protein and iron outcomes compared to other FBFs. 
 Methods 
 Animal safety and ethics 
The Institutional Animal Care and Use Committee (IACUC) at Kansas State University 
approved all animal procedures (protocols 3717.2 and 3790). 
 Diet formulation and composition 
Seven new FBFs were formulated based on USAID food aid recommendations (35) to 
compare to the current USAID FBF, CSB+ (Table 2.1). CSB+ was purchased from a USDA 
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producer (Bunge Milling, St. Louis, MO), which is prepared from heat treated corn and 
soybeans, with an added vitamin and mineral premix. To compare commodity types within the 
same FBF formulation, three white sorghum with cowpea (WSC, WSC+SPI, and N-WSC), one 
white sorghum with soy (WSS), and one corn with soybean (CSB14) blends were developed. 
FBFs were similarly produced by extruding grain and legume flours (with the exception of N-
WSC), milling them to a powder, then adding sugar (15%), oil (9%), whey protein concentrate 
(WPC) 80% (Davisco Food International, Inc., Eden Prairie, MN) or soy protein isolate (SPI) 
90% at 9.5% (ARDEX®F Dispersible 066-921, ADM, Decatur, IL), and vitamin and mineral 
premix, which was formulated according to USAID food aid recommendations (35), as 3.2% of 
FBFs (Research Products Company, Salina, KS). One sorghum and cowpea FBF was not 
extruded to determine the effects of extrusion processing (N-WSC), and the other two contained 
either an animal or plant protein source (WSC vs. WSC+SPI) to determine protein quality 
differences. Two additional sorghum-cowpea FBFs were similarly produced, however they were 
reformulated and over-processed with either whey or soy protein (O-WSC and O-WSC+SPI) to 
determine whether these FBFs meet viscosity requirements without the addition of sugar, and 
contain decreased oil (8.3%) and WPC or SPI (3%), resulting in a less expensive FBF that could 
maintain the same nutritional efficacy as the other FBFs. A 22% gamebird starter/grower diet 
(Country Lane, Orscheln Farm & Home, Moberly, MO) was fed to the control group to compare 
outcomes of FBFs with a normal chicken diet. 
Iron forms and concentrations among CSB+, new FBFs, and the control chicken diet 
were different. The control chicken diet contained ferrous sulfate (41.5 mg/100g) almost 4 times 
higher than CSB+ and an average of 2.5 times higher than new FBFs. CSB+ and new FBFs 
contained sodium iron EDTA (NaFeEDTA) and ferrous fumarate at different concentrations. 
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NaFeEDTA was included due to its superior bioavailability compared to ferrous fumarate, 
therefore the combination of the two forms were expected to enhance iron bioavailability from 
FBFs (35). 
 Fortified blended food production 
Sorghum-cowpea, sorghum-soy and corn-soy binary blends were extruded on a single 
screw extruder X-20 (Wenger Manufacturing Co., Sabetha, KS, USA) at the Kansas State 
University (KSU) Extrusion Lab. Normally processed binary blends that were extruded for 
WSC, WSC+SPI, WSS, and CSB14 FBFs shaft speed ranged from 497-564, and had an average 
dry feed rate of 171 kg/h, in-barrel moisture content of 24%, motor load of 74%, and specific 
mechanical energy of 299 kJ/kg. Over-processed binary blends that were extruded for O-WSC 
and O-WSC+SPI had a dry feed rate of 158 kg/h, in-barrel moisture content of 21%, motor load 
of 78%, and specific mechanical energy of 370 kJ/kg. Steam and water were added in the 
preconditioner at an average of 14 and 16%, respectively, for normally processed binary blends, 
and at 18 and 6%, respectively, for over-processed binary blends. Discharge temperature was 
maintained above 85°C, and the die had a single circular opening of 4.1 mm. After cutting, 
binary blend extrudates were dried using a double pass dryer/cooler (Series 4800, Wenger 
Manufacturing Co., Sabetha, KS, USA) operating at 107°C, where they were retained for 10 
minutes, before being cooled for 5 minutes at room temperature. Cooled extrudates were milled 
using a hammer mill (Schutte Buffalo, NY, USA) fitted with a 315 µm screen and collected 
directly into 50 lb 3-walled paper bags and sealed until further use. The micronutrient premix, 
whey protein concentrate or soy protein isolate, and sugar were mixed into the extruded flours in 
steps to ensure mixing uniformity. Once dry ingredients were combined through this process, oil 
was added and mixed thoroughly to produce the final FBF product. 
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 Diet and macronutrient analysis 
FBFs were analyzed by AOAC official methods by the University of Missouri-Columbia 
Agricultural Experiment Station Chemical Laboratories. Methods included measurement for total 
calories (by calculation: protein = 4kcal/g, carbohydrate = 4kcal/g, fat= 9kcal/g), protein (LECO; 
AOAC 990.03, 2006), fat (acid hydrolysis, 954.02, 2006), carbohydrates (by calculation: 100% - 
% crude protein + ash + crude fat + moisture), and amino acids including available lysine 
(AOAC Official Method 975.44; 982.30 E(a,b,c), chp. 45.3.05, 2006). 
Prepared FBFs’ viscosity was assessed in duplicate using a Bostwick Consistometer 
(CSC Scientific Company, Inc., Fairfax, Virginia, USA). All new FBFs were prepared at 20% 
solids, CSB+ was prepared at 13.79% solids as directed (33). Water was brought to a boil and the 
FBF was slowly mixed in and left to boil for 1 minute with constant stirring. CSB+ and N-WSC 
were boiled for 5 minutes with constant stirring due to their partially and non-precooked 
characteristics, respectively. After 1 or 5 minutes, the FBFs were taken off of the hot plate and 
stirred for another 30 seconds before being covered with aluminum foil and set in a water bath 
for 10 minutes at 30°C. After 10 minutes, the FBF was weighed and the lost water, due to 
evaporation, was added back. The FBF sample was recovered and put back in the water bath for 
one hour at 30°C. Then, the FBF sample was weighed once more and water was added if there 
was any loss. The FBF was stirred and poured into the Bostwick Consistometer chamber, leveled 
off, and settled for 30 seconds. Then, the gate was opened and the FBF was allowed to flow for 1 
minute until data were collected. 
 Study Design 
 Prepared FBF Study 
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Ninety 1-day old male broiler chicks were obtained from a commercial hatchery (Cobb-
Vantress, Inc., Lafayette, TN), and arrived at the KSU Poultry Unit the same day. Upon arrival, 
all chicks were immediately placed in a 5 x 13 foot floor pen. Floor pens contained sufficient 
litter covering floor, and the environmental conditions consisted of a temperature controlled 
facility with 24-hour light provided. Initial temperature of the barn was set to 34°C and by the 
end of the study was decreased to 24°C. Chicks were fed a basic broiler starter diet (O.H. Kruse 
Feed Technology Innovation Center, Manhattan, KS) that consisted of corn and soybean meal 
with micronutrients for one week before beginning experimental diets.  On day 8, chicks were 
randomized and allocated into 9 treatment diets on the basis of body weight, with 2 floor pen 
replications of 5 chicks per diet (n=10, 90 total). Animals were provided food and water (Fe 
content less than 0.11 μg/mL) ad libitum. Water was supplied by a uniform water source for the 
barn, and each pen had their own hanging tube nipple waterers. Normally, CSB+ is directed to be 
prepared at 13.79% solids, and new FBFs at 20% solids. However, due to the limited stomach 
capacity of the chickens, solids % had to be increased to make our FBFs more nutrient dense, 
and ensure they would be able to meet daily feed requirements outlined by the Cobb-Vantress, 
Inc. hatchery (98). Therefore, CSB+ was prepared at 1:2.55 solids to water, and new FBFs and 
control diet were prepared at 1:2 solids to water to account for this, while also maintaining the 
same difference between solids percentage of CSB+ and new FBFs to account for new FBFs 
increased solids when compared to CSB+. Due to their partially and non-precooked 
characteristics, CSB+ and N-WSC were boiled with water and stirred for 10 minutes in large 
turkey fryers to ensure complete cooking. For other FBFs, water was boiled together in a large 
turkey fryer, then was divided out and mixed into FBFs; room temperature water was added and 
mixed into the control diet. From days 8-23, chicks were given feed in small round plastic 
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containers with half lids (to keep chicks out of food) due to the small volume of food. Then on 
day 24, larger feeders were introduced that consisted of a 1/3 size foil steam table pan inside a 
wooden base and half covering. One days’ worth of food for each group was prepared once per 
day; 2/3 was fed to chicks in the afternoon feeding (4:00pm), and 1/3 was refrigerated overnight 
in Tupperware containers, then fed to chicks in the morning feeding (7:30am). Therefore, chicks 
were fed twice per day and food intakes were measured daily. Chicks were weighed weekly as a 
replication group until study end when they were weighed individually. Total duration fed 
treatment diets was 21 days, however at study end animals were 28 days old; study length and 
sample size were originally based on a similar published study (57). 
 Dry FBF Study 
Two hundred 1-day old male broiler chicks were obtained from a commercial hatchery 
(Cobb-Vantress, Inc., Lafayette, TN), and arrived at the KSU Poultry Unit the same day. Upon 
arrival, all chicks were immediately placed in 3.25 x 1.1 x 0.8 foot wire-bottomed battery 
brooder pens. Environmental conditions consisted of a temperature controlled facility (pens 
ranged from 26-29°C) with 24-hour light provided. Chicks were fed 22% gamebird 
starter/grower control diet (Country Lane, Orscheln Farm & Home, Moberly, MO) for four days 
before beginning experimental diets. On day 4, chicks were weighed and allocated into 8 
treatment diets on the basis of body weight with 4 battery brooder pen replications of 6 chicks 
per diet (n=24, control n=23, 191 total). The control group originally contained 24 chicks like the 
other groups, however one chick had to be terminated a few days before study end due to an 
unexplained physical injury unrelated to the study regimen. Animals were provided food and 
water (Fe content less than 0.11 μg/mL) ad libitum. Water was supplied by a uniform water 
source for the facility. Feed intakes and body weights were measured weekly as a replication 
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group until study end where a small subset (n=6) from each group were weighed individually 
and then euthanized to collect blood and liver samples to assess iron outcomes; the remaining 
chicks were transferred for farm use. Prior to termination of the study, pens were randomized so 
that 6 chickens from each diet group would be selected for euthanization and sample collection. 
Total duration fed treatment diets was 14 days, however chicks were 18 days old at study end; 
study length and sample size were based on a previous PER study (67). 
Average food intake and body weights for that replication group were readjusted to 
account for the loss of this chick. Food intake was averaged per chick, then the total intake for 
the five chicks in that replication was calculated and added together for each week. For body 
weights, since the removed chick was 12% smaller than the average of the other chicks in its 
group, we subtracted the proportioned amount of body weight from the initial and week 1 
replication body weights to obtain more realistic values. 
 Data and sample collection 
At termination of both studies, final individual weights of chickens were recorded (Prep: 
n=10, Dry: n=6). In the Prep study, gait scores were assessed by degree of impairment from 0 
(none) to 5 (complete impairment) using criteria from a modified gait scoring system outlined 
previously (99). For hemoglobin analysis, in the Prep study blood was collected via the wing 
vein into 4 mL EDTA-K2 vacuolized tubes and in the Dry study via cardiac puncture into 2 mL 
EDTA-K2 vacuolized tubes. EDTA-K2 vacuolized tubes (BD and Company, Franklin Lakes, 
NJ) were immediately placed on ice and subsequently stored at 4°C for 6-7 and 2 days before 
analysis in the Prep and Dry studies, respectively. Following blood collection, chickens were 
euthanized by cervical dislocation. Liver tissue was collected, weighed, flash frozen in liquid 
nitrogen, and stored at -80°C. In the Prep study, both legs of chickens were collected and stored 
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at -20°C for future assessment of tibiae bone mineral density via Lunar PIXImus (GE Medical 
Systems) following manufacturer instructions. 
 Iron Quantification 
 Dietary and experimental water iron 
Iron content of FBFs and control diet were analyzed in duplicate (n=9) (AACC method 
40.70.01, AIB International, Manhattan, KS). Facility water samples were collected by turning 
on water faucets for 5 minutes before taking the sample. Samples were taken in duplicate and 
iron was assessed by both flamed atomic absorption spectrometry (AAS) and inductively 
coupled plasma optical emission spectrometry (ICP-OES). AAS can detect iron levels that are at 
least 0.11 μg/mL. AAS detected no iron in our samples, therefore it can be confirmed by this 
method that the iron content in our samples were lower than 0.11 μg/mL. ICP-OES can detect 
iron concentrations of at least 0.2 μg/mL, and also failed to detect iron in the water samples. 
These concentrations are much lower than a similar study that used broiler chickens with a water 
Fe concentration of 0.379 ± 0.012 μg/mL (57). 
 Hemoglobin 
Hemoglobin samples were assessed in duplicate (Prep, n=10; Dry, n=6) using the 
QuantiChrom Hemoglobin Assay Kit (DIHB-250, BioAssay Systems, Hayward, CA), which is 
based on an improved Triton/NaOH method, following manufacturer instructions. Whole blood 
was diluted 100 fold with deionized H2O (20 µL to 1980 µL). If duplicates were more than 25% 
different, a triplicate sample was analyzed. 
 Hepatic iron 
Hepatic iron was determined in duplicate by wet ashing following procedures described 
previously (100) before quantification by inductively coupled plasma-optical emission 
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spectrometry (ICP-OES). All glassware were acid washed in a 6% nitric acid solution overnight 
before use. 1.0 g of hepatic tissue was placed into a 50 mL acid washed beaker, 10 mL of full 
strength trace metal grade nitric acid (Fisher) was slowly added, covered with a watch glass, and 
left for one hour for chemical decomposition. Samples were then placed on a hot plate and 
brought to boil, then gently refluxed for 2-3 hours until reduced to 1 mL. They were titrated to 10 
mL with deionized H2O in an acid washed volumetric flask by adding deionized H2O to the 
sample in the beaker, swirling, and transferring to the flask. The final sample was then mixed 
again and transferred to a 15 mL sterile polypropylene tube and stored at room temperate until 
quantified in duplicate (Prep, n=10; Dry, n=6) by ICP-OES (Varian 720-ES, Agilent 
Technologies, Santa Clara, CA). If duplicates were more than 25% different, a triplicate sample 
was analyzed. 
 Tibiae bone mineral density 
Right legs of chickens from the Prep study (n=10), were brought to room temperature 
before tibiae were dissected and bone mineral density (BMD) measured via Lunar PIXImus (GE 
Medical Systems). Four BMD measurements were taken due to reports of BMD varying across 
the regions of the tibia (101). The first measurement analyzed BMD of the entire tibia (Total 
BMD). The second measurement analyzed the diaphysis region (Diaphysis BMD), which was 
defined as the middle 50% region of the tibia (102). The third and fourth measurements analyzed 
the BMD of the proximal (Proximal BMD) and distal (Distal BMD) epiphyses, defined as the top 
and bottom 25% regions of the tibia (102). Total lengths of the tibiae were first measured, and 
regions were calculated from lengths and visibly marked. Tibiae were placed in the scanning 
area, and metal references were placed adjacent to marks so the region of interest could be 
adjusted on the PIXImus once scanned to obtain each BMD measurement. 
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 Calculations 
Caloric efficiency was calculated along with protein efficiency as an indicator of protein 
quality. Means of replication groups for each experimental diet were used. 
Caloric efficiency (weight gain per kcal consumed) =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 (𝑔)
𝑓𝑜𝑜𝑑 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑔) 𝑥 𝑘𝑐𝑎𝑙 𝑝𝑒𝑟 𝑔𝑟𝑎𝑚 𝑜𝑓 𝐹𝐵𝐹
 
Protein efficiency (weight gain per gram of protein consumed) =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 (𝑔)
𝑡𝑜𝑡𝑎𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑔)
 
Feed conversion ratio (FCR) was also calculated, which is widely used in poultry 
production to assess efficiency in converting feed into mass (103).  
Feed conversion ratio (grams feed intake per gram weight gain) =
𝑓𝑒𝑒𝑑 𝑖𝑛𝑡𝑎𝑘𝑒 (𝑔)
𝑤𝑒𝑖𝑔ℎ𝑡 𝑔𝑎𝑖𝑛 (𝑔)
 
 Statistical analysis 
Group differences were assessed using one-way ANOVA and least significant differences 
comparisons method at significance level p<0.05 using SAS Studio 3.6 (Cary, NC). Natural log 
transformation was used if the assumption of normality was violated. 
 Results 
 FBF analyzed composition and viscosity 
 Composition 
CSB+ contained on average 6.5% fewer total kcals, 15.6% less protein, and was within 
1.1% of carbohydrate content compared to new FBFs (Table 2.3). CSB+ contained similar fat 
content to both over-processed FBFs (O-WSC and O-WSC+SPI), and collectively these FBFs 
contained 20.7% less fat than non-extruded (N-WSC) and normally extruded FBFs (WSC, 
WSC+SPI, WSS, CSB14). O-WSC, O-WSC+SPI, and N-WSC provided less total kcal per 100g 
FBF, and the two over-processed FBFs contained less available lysine compared to other FBFs, 
but more than CSB+. CSB+ contained 36.5% less iron than new FBFs, and the control diet 
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contained markedly higher iron than new FBFs and CSB+. WPC versus SPI containing groups 
had comparable macro- and micronutrient compositions. 
 Viscosity 
Required USAID Bostwick consistency values for corn-soy blend are 9 to 21 cm (104). 
Normally extruded sorghum-containing FBFs (WSC, WSC+SPI, and WSS) on average were 
43.5% more viscous than corn-containing FBFs (CSB14 and CSB+; Table 2.4). Over-processing 
of sorghum and cowpea (O-WSC and O-WSC+SPI) allowed FBFs to reach viscosity 
requirements without the addition of sugar. N-WSC did not meet viscosity requirements; WSC 
and WSS slightly exceeded requirements. 
 Food intake, body weight, food efficiency, iron, and anthropomorphic outcomes 
 Prepared FBF Study 
The control group significantly increased food intake and weight gain compared to all 
FBF groups (Table 2.5). WSS consuming group had significantly higher food intake compared to 
N-WSC, O-WSC+SPI, and WSC consuming groups. 
The WSS consuming group had significantly increased body weight gain compared to all 
FBFs, with the exception of CSB14 and O-WSC. Of the sorghum-cowpea groups, O-WSC+SPI 
had significantly reduced body weight gain compared to O-WSC and WSC+SPI, but not WSC or 
N-WSC. CSB+ had reduced body weight gain compared to all FBFs, with the exception of WSC 
and O-WSC+SPI, despite having a higher food intake compared to many of the FBF groups. 
The WSS consuming group had significantly higher final body weight compared to all 
FBFs, with the exception of CSB14. The O-WSC+SPI group had significantly decreased final 
body weight compared to WSS, CSB14, O-WSC, and WSC+SPI. With the exception of O-
WSC+SPI, all other sorghum-cowpea FBFs had similar final body weights. 
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CSB+ significantly reduced caloric efficiency compared to all groups, by 24% compared 
to the next least efficient group, O-WSC+SPI. Caloric efficiency was significantly greater in the 
WSS consuming group than all the other FBF groups, except for N-WSC. N-WSC significantly 
improved caloric efficiency compared to O-WSC and O-WSC+SPI. 
There was a significant reduction in protein efficiency in the CSB+ group compared to all 
other groups. Protein efficiency was significantly greater in the WSS consuming group than all 
groups, with the exception of N-WSC and CSB14. WSC+SPI was not significantly different than 
WSC, O-WSC, or N-WSC. However, O-WSC+SPI had significantly reduced protein efficiency 
compared all FBFs.  
CSB+ consuming group had significantly higher food conversation ratio than all other 
FBF groups (37% more than next least efficient group, O-WSC+SPI), indicating they were the 
least efficient at converting feed to weight gain. The WSS consuming group had the most 
efficient feed conversion ratio; it was not significantly different than CSB14, N-WSC, 
WSC+SPI, and control groups. 
There were no significant differences in hemoglobin concentration between groups 
(Table 2.6). The control group had significantly reduced hepatic iron levels compared to all 
groups, with the exception of CSB+. O-WSC+SPI consuming group had the highest hepatic iron 
levels, however it was not significantly higher than O-WSC and WSC+SPI groups. Liver weight 
as a percentage of body mass was significantly higher in the WSC consuming group compared to 
control, CSB14, and WSS groups. 
Some chickens developed gait issues during the study, and thus gait scores were 
collected. N-WSC and WSC consuming groups had significantly increased gait scores compared 
to all other groups (Table 2.7). CSB14 and WSS groups also had gait scores that were 
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significantly greater than the other groups that did not have any impairment. To determine if this 
impairment was due to bone weakness in their legs, bone mineral densities were collected on 
right tibias. The WSS group had the highest total bone mineral density compared to other FBFs, 
but not significantly higher than WSC+SPI, O-WSC, and CSB14 groups. WSC had the lowest 
total bone mineral density, but not significantly lower than N-WSC, CSB+, and O-WSC+SPI. 
WSC+SPI had the highest total diaphysis bone mineral density compared to other FBFs, but not 
significantly higher than O-WSC, WSS, CSB14, and O-WSC+SPI. WSC had the lowest 
diaphysis bone mineral density, but not significantly lower than N-WSC, CSB+, and O-
WSC+SPI. WSS had significantly higher proximal bone mineral density compared to all other 
FBFs. WSS had significantly higher distal bone mineral density compared to all other FBFs, with 
the exception of WSC+SPI and O-WSC. For all bone mineral density measurements, WSC had 
significantly reduced BMD, but not significantly different than N-WSC, CSB+, and O-
WSC+SPI.  
 Dry FBF Study 
The control group significantly increased food intake and weight gain compared to all 
FBF groups (Table 2.8). CSB+ consuming group ate significantly less total food compared to all 
other groups, with the exception of O-WSC+SPI. The WSS consuming group ate significantly 
more food compared to all other groups, with the exception of CSB14. Of the sorghum-cowpea 
groups, WSC consuming group ate significantly more than WSC+SPI, O-WSC, and O-
WSC+SPI consuming groups. 
CSB+ and O-WSC+SPI consuming groups gained significantly less weight than all other 
groups. WSS consuming group gained significantly more weight compared to all other groups, 
except for WSC.  
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CSB+ and O-WSC+SPI had significantly lower final body weights compared to all other 
FBFs. WSS and WSC groups had significantly increased final body weight compared to all other 
FBFs. 
O-WSC, WSS, WSC, and WSC+SPI significantly increased caloric efficiency compared 
to CSB14, O-WSC+SPI, and CSB+. The CSB+ consuming group had significantly reduced 
caloric efficiency compared to all groups, with the exception of O-WSC+SPI. 
There was a significant reduction in protein efficiency with O-WSC+SPI compared to all 
other groups, with the exception of CSB+. Protein efficiency was significantly greater in the O-
WSC consuming groups than all groups, with the exception of WSS and WSC.  
CSB+ consuming group had significantly increased (less efficient) FCR compared to all 
groups. Among new FBFs, O-WSC+SPI group had significantly higher FCR, with the exception 
of CSB14. The WSS group nonsignificantly reduced FCR among all FBFs, indicating it was the 
most efficient at converting feed into weight gain. 
The CSB+ consuming group had significantly increased hemoglobin levels compared to 
all others groups (Table 2.9). There were no other significant differences between FBF groups’ 
hemoglobin levels. The CSB+ consuming group had significantly reduced hepatic iron levels 
compared to all other FBF consuming groups. O-WSC+SPI consuming group had significantly 
higher levels compared to other groups, with the exception of WSC+SPI and O-WSC. 
 Overall Results 
Overall, CSB+ and O-WSC+SPI trended towards reduced food efficiency outcomes 
compared to all other groups. In the Prep study, CSB+ nonsignificantly increased and decreased 
food intake and weight gained, respectively, compared to all groups. In the Dry study, with the 
exception of O-WSC+SPI, CSB+ significantly reduced both food intake and weight gained 
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compared to all groups. In the Prep study, CSB+ significantly reduced caloric and protein 
efficiencies, and significantly increased feed conversion ratio, compared to all groups. In the Dry 
study, CSB+ significantly reduced caloric efficiency (with exception of O-WSC+SPI), protein 
efficiency (with exception of WSC+SPI, O-WSC+SPI, and CSB14), and significantly increased 
feed conversion ratio compared to all groups. New FBFs, with the exception of O-WSC+SPI, 
performed similarly in both studies for food intake, weight gain, and food efficiency outcomes, 
although WSS trended towards improved outcomes. 
Regarding iron outcomes, CSB+ significantly increased hemoglobin levels compared to 
all groups in the Dry study, however in both studies there were no significant differences 
between other groups. In both studies, O-WSC+SPI tended to nonsignificantly increase hepatic 
iron levels, while CSB+ nonsignificantly and significantly reduced levels in the Prep and Dry 
studies, respectively, compared to new FBFs which had similar levels.  
 Comparing FBFs to NRC recommendations 
Due to significantly higher outcomes observed in the control group and gait issues 
identified in the Prep study, FBFs were compared with NRC requirements for protein, amino 
acid, and certain minerals. FBFs did not meet protein, certain amino acid, calcium, or 
phosphorus requirements for broiler chickens 0 to 21 days old, however calorie and iron 
requirements were exceeded by all FBFs (105; Table 2.10). CSB+ contained less lysine 
compared to other FBFs, which may have contributed to lower growth seen in the Dry study, 
however O-WSC+SPI had comparable nutrient content to other new FBFs, and its consumption 
resulted in outcomes similar to CSB+. 
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 Discussion 
In these studies, with the exception of O-WSC+SPI, new FBFs resulted in improved food 
efficiency and hepatic iron outcomes compared to the current USAID FBF, CSB+. New FBFs 
resulted in similar protein and iron outcomes, with the exception of O-WSC+SPI, suggesting 
sorghum and cowpea are suitable replacements for corn and soy, SPI is an effective alternative to 
WPC, and reformulated, over-processed FBFs with WPC can be considered as a less expensive 
FBF option. 
Overall, CSB+ trended towards reduced food efficiency outcomes compared to new 
FBFs, with the exception of O-WSC+SPI. Although CSB+ contained lower caloric and protein 
content compared to new FBFs, all FBFs did not meet protein, but did exceed calorie and fat 
recommendations for broiler chickens 0-21 days, therefore it is not likely this slight decrease in 
protein content significantly reduced food efficiency outcomes that were observed. In a study 
with similar new FBFs and CSB+ fed to rats, CSB+ resulted in decreased food intake, growth 
suppression, and reduced caloric and protein efficiencies compared to other groups (100). 
Additionally, CSB+ inhibited growth in week 1 despite similar food intake with other groups 
(100); this suggests poorer food quality and digestibility in CSB+ compared to new FBFs. In 
another study with energy sufficient, but decreased lysine content in the diet, broiler chickens 
had significantly lower weight gain compared to other groups (106). Similarly, CSB+ contained 
sufficient energy but lower lysine compared to new FBFs, and significantly lower weight gain 
was observed in the Prep study compared to WSS and CSB14, and in the Dry study compared to 
all groups except for O-WSC+SPI; this suggests lower protein quality compared to new FBFs. 
Extrusion processing has been cited often to improve cereal and legume starch and amino acid 
digestibility (107-110), therefore lack of extrusion and reduced digestibility of CSB+ may have 
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been the primary factors that caused the increased difference between food intake and weight 
gain compared to other FBFs, and thus resulted in significantly reduced food efficiencies in the 
Prep study. However, it is important to note that the non-extruded FBF in the Prep study, N-
WSC, performed similar to other new FBFs, and nonsignificantly improved weight gain while 
significantly improving food efficiencies compared to CSB+, despite it being non-precooked and 
thus requiring the same amount of boiling time to cook it like CSB+. This suggests that the 
nutritional quality of N-WSC is higher than CSB+, and that the absence of extrusion processing 
did not significantly affect the FBF’s digestibility; although N-WSC did not meet viscosity 
requirements, thus limiting its viability. In another study feeding similar extruded FBFs to rats, 
phytate content was analyzed and extruded FBFs’ phytate content was reduced by more than 
three times compared to CSB+ (100). In rats, amino acid bioavailability reduction has been 
observed with consumption of phytate containing foods due to effect on digestive enzyme 
activity (111), however this has only been observed to affect iron bioavailability in broiler 
chickens (85, 86). In addition, N-WSC and O-WSC performed comparably to other FBFs in the 
Prep study, and O-WSC even nonsignificantly improved food efficiencies in the Dry study, 
despite their potentially increased polyphenolic content due to non-extrusion and increase in 
phytate-containing grain and legume by volume, respectively, compared to other FBFs. 
Therefore, it is important to note but unlikely that differences in phytate content played a 
substantial role in the significant and nonsignificant reduction of food efficiencies in the CSB+ 
consuming group for both studies. 
Along with CSB+, O-WSC+SPI significantly reduced food intake, body weight gain, 
final body weight, and food efficiencies in the Dry study, and in the Prep study consistently but 
nonsignificantly reduced these outcomes as well. However, the similarly reformulated, over-
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processed FBF with WPC, O-WSC, significantly improved food efficiency outcomes in both 
studies compared to O-WSC+SPI. It is possible that for this particular formulation of FBF, SPI is 
not sufficient compared to WPC for improving these outcomes. However, the other SPI 
containing group, WSC+SPI, performed similarly in both studies to its identically formulated 
counterpart but with WPC, WSC, suggesting that in certain formulations of FBFs, soy protein is 
an effective alternative to whey protein. Additionally, this is supported in a review that found 
isocaloric, isonitrogenous animal source proteins were not superior to plant source proteins in 
enhancing linear growth, suggesting the costly inclusion of animal source proteins are not needed 
in FBFs (11). Therefore, in the case of O-WSC+SPI, it is maybe that since the majority of 
protein coming from cowpea flour that SPI could not make up for its lower protein quality like 
WPC. 
Regarding iron outcomes, hemoglobin levels were not significantly different in the Prep 
study among all groups. However, in the Dry study, CSB+ significantly increased and reduced 
hemoglobin and hepatic iron levels, respectively, compared to all new FBFs. In one study, low 
ambient temperature (24-26°C from 1-7 days, 9-11°C from 8-21 days) expectedly increased 
hemoglobin levels due to oxidative stress of broiler chickens, and addition of a vitamin C 
supplement unexpectedly, but nonsignificantly, increased hemoglobin levels in 21-day-old 
broiler chickens compared to normal ambient temperature (29-31°C from 1-7 days, 24-26°C 
from 8-21 days) and non-supplemented groups (112). Although temperatures during this study 
were in the normal ambient temperature range, oxidative stress still may have been present in 
CSB+ chicks which caused the tissues’ demand for oxygen, and thus increased need for 
mobilizing iron in hemoglobin rather than storage that was observed. In both studies, O-
WSC+SPI significantly increased hepatic iron content compared to other FBFs, with the 
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exception of O-WSC and WSC+SPI. This was most likely due to markedly slower growth rates, 
and thus less demand for micronutrients; similar outcomes were observed in another study with 
CSB+ in rats (100). There were no observed signs that suggested micronutrient deficiencies, and 
their livers were not enlarged compared to other groups, suggesting iron toxicity was not likely a 
factor in their growth suppression.  
In the Prep study, gait issues were present in N-WSC, WSC, CSB14, and WSS. WSC 
consistently nonsignificantly reduced BMD across all measurements, along with N-WSC, CSB+, 
and O-WSC+SPI, however the latter two groups did not have gait issues. The primary factors 
being cited for occurrence of leg disorders, including locomotion issues represented by high gait 
score, are rapid growth and weight gain, and decreased locomotor activity (95, 113, 114). 
However in this study, chickens impacted had slow growth and weight gain, and had large pens 
with food and water sources spread apart, thus requiring more walking. Collectively, locomotor 
activity was not restricted. In addition, control diet consuming groups had significantly increased 
growth and weight gain, more comparable to commercial broilers, but no gait issues were 
observed in this group. BMD is affected by age, sex, type of production, diet, and management 
(115), and tibia BMD has been cited to linearly increase with increasing levels of nonphytate 
phosphorus, and constant calcium content at 1.0% of diet (116). All FBFs did not meet NRC 
calcium (1000mg/100g) or phosphorus requirements (450mg/100g), and both mineral levels 
were the same across all new FBFs. It is not clear what caused gait issues in some FBF groups 
and not others, however certainly low calcium and phosphorus content in FBFs contributed to 
low BMD of chicks compared to control groups in this study. 
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 Limitations 
The locomotion impairment observed in some chicks in the Prep study may have caused 
decreased food intake or activity, and thus had a minor effect on overall outcomes for those 
groups. Although the ratio of solids between new FBFs and CSB+ remained the same as 
normally directed, the decreased solids of CSB+ could have contributed to the reduced food 
efficiencies that were seen. However, this also demonstrates the limitations of CSB+ in treating 
children for malnutrition in food aid programs due to their limited stomach capacity, and thus 
need for a more nutrient-dense FBF such as our new FBFs is important to consider (35). Both of 
these studies were short in duration, therefore results from this rapid growth period have to be 
translated with caution to humans. FBFs are normally meant to be consumed along with other 
foods, therefore the complementary feeding nature of FBFs to improve outcomes is limited in 
these studies.  
 Conclusions 
In conclusion, sorghum and cowpea FBFs performed similarly to corn and soy FBFs, 
suggesting these commodities are suitable replacements for corn and soy. Soy protein isolate 
(WSC+SPI) was an effective alternative to whey protein concentrate (WSC), suggesting SPI can 
be a less expensive protein supplement in FBFs. Surprisingly, non-extruded sorghum and 
cowpea (N-WSC) was equally efficacious to extruded WSC, suggesting extrusion may not be 
necessary for improving protein and iron bioavailability from FBFs with this specific 
formulation. However, it should be noted that N-WSC did not meet viscosity requirements and 
requires cooking before consumption, thus limiting its viability. O-WSC+SPI resulted in poorer 
outcomes compared to other FBFs, which suggests the protein quality of cowpea may be inferior 
and the inclusion of whey protein is needed in this formulation, as O-WSC with whey performed 
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similarly to other FBFs. Therefore, reformulated over-processed FBFs with the inclusion of 
whey protein can be considered as a less expensive FBF option. Overall, new FBFs, with the 
exception of O-WSC+SPI, resulted in improved food efficiency and hepatic iron outcomes 
compared to CSB+, suggesting they are of higher nutritional quality. However, further research 
is needed to refine and identify the best FBF formulations. 
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 Tables 
Table 2.1 FBFs composition (%) 
 
Sorghum 
flour 
Cowpea 
flour 
Soy 
flour 
Corn 
flour 
Sugar 
Whey 
protein 
concentrate 
Soy 
protein 
isolate 
Vegetable 
oil 
Micro-
nutrient 
premix 
WSC, 
N-WSC 
24.7 38.6 0 0 15 9.5 0 9.0 3.2 
WSC + SPI 24.7 38.6 0 0 15 0 9.5 9.0 3.2 
O-WSC 31.5 54.0 0 0 0 3.0 0 8.3 3.2 
O-
WSC+SPI 
31.5 54.0 0 0 0 0 3.0 8.3 3.2 
WSS 47.6 0 15.7 0 15 9.5 0 9.0 3.2 
CSB14 0 0 15.2 48.1 15 9.5 0 9.0 3.2 
CSB+: Whole corn (78.4), whole roasted soy (20), vitamin mineral (0.2), tri-calcium phosphate (1.16), potassium 
chloride (0.17) 
Control chicken diet based on label ingredients: Grain products, plant protein products, processed grain by-products, 
roughage products, vitamin supplements, minerals. 
White sorghum-cowpea (WSC), Non-extruded WSC (N-WSC), WSC + soy protein isolate (WSC+SPI), Over-
processed WSC (O-WSC), Over-processed WSC + soy protein isolate (O-WSC+SPI), White sorghum-soy (WSS), 
Corn-soy blend 14 (CSB14), Corn-soy blend plus (CSB+). 
 
Table 2.2 New FBFs and CSB+ vitamin and mineral fortificant levels (mg/100g) 
New FBFs   CSB+  
Vitamin A Palmitate 0.488 Vitamin A Retinyl Ester 1.04 
Thiamin Mononitrate (B1) 0.652 Thiamin Mononitrate (B1) 0.2 
Riboflavin (B2) 0.933 Riboflavin (B2) 1.4 
Niacinamide (B3) 9.07 Niacinamide (B3) 8.0 
Calcium D-Pantothenate (B5) 3.646 Calcium D-Pantothenate (B5) 1.6 
Pyridoxine Hydrochloride (B6) 0.752 Pyridoxine Hydrochloride (B6) 1.0 
Folic Acid (B9) 0.087 Folic Acid (B9) 0.11 
Vitamin B12 0.0015 Vitamin B12 0.002 
Vitamin D3 0.0292 Vitamin D3 0.011 
Vitamin E 13.224 Vitamin E 8.3 
Vitamin K 0.033 Vitamin K 0.03 
Coated Ascorbic Acid 40.0 Coated Ascorbic Acid 90.0 
Calcium (Tri-Calcium Phosphate) 279.08 Calcium (Tri-Calcium Phosphate) 452 
Iron 
   Sodium Iron EDTA                                          
   Ferrous Fumarate 
13.0 
      1.47 
       3.79 
 Iron  
    Sodium Iron EDTA 
    Ferrous Fumarate 
6.5 
   1.12 
   2.44 
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Iodine (Potassium Iodide) 0.23 Iodine (Potassium Iodide) 0.04 
Phosphorus (Tri-Calcium Phosphate) 290.97 Phosphorus (Tri-Calcium Phosphate) 290 
Potassium (Potassium Monophosphate) 163.19  Potassium (Potassium Chloride) 140 
Zinc Sulfate 5.50 Zinc Sulphate Monohydrate 5.0 
Magnesium Oxide 9.47   
Sodium Chloride 225.67   
New FBFs: White sorghum-cowpea (WSC), Non-extruded WSC (N-WSC), WSC + soy protein isolate (WSC+SPI), 
Over-processed WSC (O-WSC), Over-processed WSC + soy protein isolate (O-WSC+SPI), White sorghum-soy 
(WSS), Corn-soy blend 14 (CSB14); CSB+: Corn-soy blend plus. 
 
Table 2.3 Analyzed macronutrient, selected amino acid, and iron content 
 WSC WSC+SPI N-WSC O-WSC 
O-WSC+ 
SPI 
WSS CSB14 CSB+ 
Total 
Calories 
(kcal/100g) 
412.8 418.4 402.7 403.0 401.7 411.7 429.5 384.8 
Carbohydrate 
(g/100g) 
62.6 61.2 59.4 64.3 63.8 62.7 60.6 61.3 
Protein 
(g/100g) 
19.1* 19.8* 18.1* 17.9* 18.4* 19.5* 18.4* 15.8* 
Fat (g/100g) 9.6 10.5 10.3 8.3 8.1 9.2 12.7 8.5 
Ash (g/100g) 3.9 3.7 3.6 3.9 4.2 3.5 3.2 3.6 
Crude Fiber 
(g/100g) 
0.6 0.6 0.7 0.8 0.9 0.6 0.5 2.1 
Moisture 
(g/100g) 
4.3 4.3 7.9 4.8 4.7 4.5 4.8 8.8 
Lysine 
(mg/g) 
14.0 11.8 13.5 10.8 10.4 13.3 12.6 8.5* 
Cysteine + 
methionine 
(mg/g) 
6.3* 4.8* 6.0* 4.7* 4.4* 7.0* 6.5* 5.2* 
Available 
lysine (mg/g) 
13.4 11.2 13.1 9.7 9.5 12.8 12.0 8.2* 
Iron 
(mg/100g) 
17.2 16.8 16.2 16.5 16.8 15.9 16.0 10.5 
White sorghum-cowpea (WSC), Non-extruded WSC (N-WSC), WSC + soy protein isolate (WSC+SPI), Over-
processed WSC (O-WSC), Over-processed WSC + soy protein isolate (O-WSC+SPI), White sorghum-soy (WSS), 
Corn-soy blend 14 (CSB14), Corn-soy blend plus (CSB+). 
*Lower than NRC requirements for broiler chickens 0-42 days (105). 
Note: The control chicken diet is formulated to provide 230.2 kcal/100g* and contain 22 g/100g protein and 41.5 
mg/100g iron; Macronutrient and micronutrient content analyzed in duplicate (macronutrients and amino acids, 
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AOAC official methods, University of Missouri-Columbia Agricultural Experiment Station Chemical Laboratories, 
Columbia, MO; iron, AIB International, Manhattan, KS). 
 
Table 2.4 FBF viscosity outcomes 
FBF Time to Cook (min) Average Bostwick Value (cm/min) 
WSC 1 21.5 
WSC+SPI 1 18.75 
N-WSC 5 5 
O-WSC 1 11 
O-WSC+SPI 1 11.25 
WSS 1 21.5 
CSB14 1 13.25 
CSB+ (13.79% solids) 5 10 
New FBFs prepared at 20% solids. 
White sorghum-cowpea (WSC), Non-extruded WSC (N-WSC), WSC + soy protein isolate (WSC+SPI), Over-
processed WSC (O-WSC), Over-processed WSC + soy protein isolate (O-WSC+SPI), White sorghum-soy (WSS), 
Corn-soy blend 14 (CSB14), Corn-soy blend plus (CSB+). 
 
 Prepared FBF Study Outcomes 
Table 2.5 Food intake, body weight, and food efficiencies (n=10) 
 Control WSC WSC+SPI N-WSC O-WSC 
O-
WSC+SPI 
WSS CSB14 CSB+ 
Total Food 
Intake (g) 
6120.2 
± 82.7a 
1759.2 
± 
103.9b 
2217.8 ± 
53.3bcd 
1946.6 
± 58.1bc 
2592.4 
± 61.3cd 
1928.4 ± 
177.6b 
3023.3 
± 131.2d 
2445.9 
± 
36.4bcd 
2989.3 
± 66.3d 
Total Weight 
Gained (g) 
1065.0 
± 16.4a 
292.3 
± 
23.6bd 
404.9 ± 
10.9bc 
354.9 ± 
19.0bcd 
418.9 ± 
13.3bce 
265.6 ± 
32.5d 
623.0 ± 
22.4e 
459.6 ± 
15.1ce 
295.6 ± 
8.3bd 
Final Body 
Weight (g) 
1165.6 
± 15.3a 
390.8 
± 
23.5bc 
505.4 ± 
11.8be 
456.2 ± 
19.8bce 
518.6 ± 
12.6be 
363.7 ± 
32.9c 
723.7 ± 
21.5d 
561.1 ± 
14.3de 
396.3 ± 
7.9bc 
Caloric 
Efficiency 
(g/kcal x 
1000) 
16.5 ± 
0.0a 
9.1 ± 
0.2bc 
9.7 ± 0.0bc 
10.1 ± 
0.2be 
8.9 ± 
0.1c 
7.6 ± 0.2d 
11.2 ± 
0.1e 
9.8 ± 
0.2bc 
5.7 ± 
0.0f 
Protein 
Efficiency 
(g/g) x100 
17.3 ± 
0.0a* 
19.6 ± 
0.4b 
20.5 ± 
0.0bd 
22.5 ± 
0.5cd 
20.1 ± 
0.2b 
16.5 ± 
0.5a 
23.6 ± 
0.2c 
23.0 ± 
0.4c 
14.0 ± 
0.1e 
Feed 
Conversion 
105.1 ± 107.0 98.7 ± 98.4 ± 111.1 ± 132.5 ± 86.9 ± 95.0 ± 181.2 ± 
54 
Ratio (g/g) 
x100 
0.3ab ± 2.3b 0.2ab 2.2ab 0.9b 4.2c 0.7a 1.6a 1.2d 
*Based on label values rather than analyzed values. 
Data are mean ± SEM; values with different letters are statistically different (p<0.05). 
White Sorghum-Cowpea (WSC), WSC + Soy Protein Isolate (WSC+SPI), Non-extruded WSC (N-WSC), Over-
processed WSC (O-WSC), O-WSC + Soy Protein Isolate (O-WSC+SPI), White Sorghum- Soybean (WSS), Corn-
Soybean Blend 14 (CSB14), Corn-Soybean Blend + (CSB+). 
 
Table 2.6 Circulating and hepatic iron levels, and liver weight per body weight (n=10) 
 Control WSC WSC+SPI N-WSC O-WSC 
O-
WSC+SPI 
WSS CSB14 CSB+ 
Hemoglobin 
(g/dL) 
8.2 ± 
0.5 
10.0 ± 
0.7 
8.7 ± 0.6 
9.4 ± 
0.9 
8.7 ± 
0.5 
8.3 ± 0.4 
8.9 ± 
0.7 
8.9 ± 
1.1 
8.5 ± 
1.4 
Hepatic Iron 
(µg/g) 
13.5 ± 
1.4a 
22.6 ± 
3.6bc 
27.5 ± 
4.0cd 
21.3 ± 
1.6bc 
30.1 ± 
3.6cd 
35.3 ± 
4.2d 
22.2 ± 
2.8bc 
24.5 ± 
4.0bc* 
18.9 ± 
4.0ab 
Liver 
Weight per 
Body 
Weight (%) 
x100 
2.4 ± 
0.2a 
3.3 ± 
0.4b 
3.0 ± 
0.1abc 
3.0 ± 
0.2abc 
2.8 ± 
0.2abc 
3.2 ± 0.1bc 
2.7 ± 
0.3ac 
2.6 ± 
0.1ac* 
2.8 ± 
0.1abc 
*n=9 
Data are mean ± SEM; values with different letters are statistically different (p<0.05). 
White Sorghum-Cowpea (WSC), WSC + Soy Protein Isolate (WSC+SPI), Non-extruded WSC (N-WSC), Over-
processed WSC (O-WSC), O-WSC + Soy Protein Isolate (O-WSC+SPI), White Sorghum- Soybean (WSS), Corn-
Soybean Blend 14 (CSB14), Corn-Soybean Blend + (CSB+). 
 
Table 2.7 Gait scores and bone mineral density outcomes (n=10) 
 Control WSC WSC+SPI N-WSC O-WSC 
O-
WSC+SPI 
WSS CSB14 CSB+ 
Gait Score 
(+1) 
1.0 ± 
0.0a 
3.4 ± 
0.6b 
1.0 ± 0.0a 
3.9 ± 
0.6b 
1.0 ± 
0.0a 
1.0 ± 0.0a 
1.8 ± 
0.6ac 
2.1 ± 
0.6c 
1.0 ± 
0.0a 
Total BMD 
(g/cm2) x100 
21.1 ± 
0.5a 
8.4 ± 
0.4b 
11.7 ± 
0.3c 
9.1 ± 
0.5b 
11.6 ± 
0.7c 
9.6 ± 0.5bd 
12.0 ± 
0.6c 
10.6 ± 
0.3cd 
9.2 ± 
0.3b 
Diaphysis 
BMD 
(g/cm2) x100 
25.6 ± 
0.7a 
9.3 ± 
0.4b 
12.1 ± 
0.3c 
9.3 ± 
0.4b 
12.1 ± 
0.6c 
10.3 ± 
0.6bc 
11.8 ± 
0.6c 
11.0 ± 
0.4c 
9.7 ± 
0.3b 
Proximal 
BMD 
(g/cm2) x100 
17.3 ± 
0.3a 
7.9 ± 
0.5b 
11.1 ± 
0.4c  
9.0 ± 
0.6b 
11.0 ± 
0.6c 
8.8 ± 0.5b 
12.3 ± 
0.5d 
10.8 ± 
0.3c 
8.5 ± 
0.2b 
Distal BMD 
(g/cm2) x100 
19.1 ± 
0.5a 
8.0 ± 
0.6b 
11.8 ± 
0.3c 
8.8 ± 
0.6bd 
11.7 ± 
0.8c 
9.5 ± 0.6bd 
12.1 ± 
0.6c 
9.8 ± 
0.4d 
9.3 ± 
0.3bd 
Gait Scores: increased by 1 to be able to analyze data in SAS. 1 = no impairment, up to 6 = complete lameness (99). 
BMD: bone mineral density. 
Data are mean ± SEM; values with different letters are statistically different (p<0.05). 
55 
White Sorghum-Cowpea (WSC), WSC + Soy Protein Isolate (WSC+SPI), Non-extruded WSC (N-WSC), Over-
processed WSC (O-WSC), O-WSC + Soy Protein Isolate (O-WSC+SPI), White Sorghum- Soybean (WSS), Corn-
Soybean Blend 14 (CSB14), Corn-Soybean Blend + (CSB+). 
 
 Dry FBF Study Outcomes 
Table 2.8 Food intake, body weight outcomes, and food efficiencies 
 
Control 
n=23 
WSC 
n=24 
WSC+SPI 
n=24 
O-WSC 
n=24 
O-
WSC+SPI 
n=24 
WSS 
n=24 
CSB14 
n=24 
CSB+ 
n=24 
Total Food 
Intake (g) 
889.5 ± 
3.3a 
325.1 ± 
2.5b 
286.5 ± 5.5c 
284.1 ± 
2.7c 
209.4 ± 
3.0d 
360.0 ± 
6.4e 
327.9 ± 
6.1be 
248.9 ± 
2.4f 
Total Weight 
Gained (g) 
575.3 ± 
2.9a 
141.4 ± 
1.0bd 
125.9 ± 
3.4b 
126.9 ± 
2.8b 
75.6 ± 1.7c 
163.1 ± 
4.0d 
131.2 ± 
4.6b 
79.0 ± 
2.2c 
Final Body 
Weight (g) 
663.6 ± 
2.9a 
229.7 ± 
1.1bd 
212.8 ± 
3.6b 
215.1 ± 
2.6b 
163.0 ± 2.1c 
251.3 ± 
4.2d 
221.3 ± 
4.8b 
167.4 ± 
2.4c 
Caloric 
Efficiency 
(g/kcal) x1000 
49.3 ± 
1.3a 
17.6 ± 
0.2b 
17.5 ± 0.1b 
18.4 ± 
0.2b 
14.9 ± 0.1cd 
18.3 ± 
0.2b 
15.5 ± 
0.3c 
13.7 ± 
0.3d 
Protein 
Efficiency 
(g/g) x100 
51.6 ± 
1.3a* 
38.0 ± 
0.3bc 
37.0 ± 0.3be 
41.5 ± 
0.5c 
32.7 ± 0.3d 
38.7 ± 
0.5bc 
36.2 ± 
0.8bd 
33.4 ± 
0.6de 
Feed 
Conversion 
Ratio (g/g) 
x100 
27.0 ± 
0.4a 
38.3 ± 
0.4bd 
38.1 ± 0.3bd 
37.5 ± 
0.5b 
46.4 ± 0.5c 
36.9 ± 
0.4b 
42.2 ± 
0.9cd 
53.0 ± 
1.0e 
*Based on label values rather than analyzed values. 
Data are mean ± SEM; values with different letters are statistically different (p<0.05). 
White Sorghum-Cowpea (WSC), WSC + Soy Protein Isolate (WSC+SPI), Over-processed WSC (O-WSC), O-WSC 
+ Soy Protein Isolate (O-WSC+SPI), White Sorghum- Soybean (WSS), Corn-Soybean Blend 14 (CSB14), Corn-
Soybean Blend + (CSB+). 
 
Table 2.9 Circulating and hepatic iron levels, and liver weight per body weight (n=6) 
 Control WSC WSC+SPI O-WSC 
O-
WSC+SPI 
WSS CSB14 CSB+ 
Hemoglobin 
(g/dL) 
9.2 ± 
0.9a 
9.4 ± 
0.1a 
8.5 ± 0.6a 8.8 ± 0.3a 8.6 ± 0.3a 9.6 ± 0.4a 9.5 ± 0.5a 
12.4 ± 
0.4b 
Hepatic Iron 
(µg/g) 
7.9 ± 
1.1a 
17.6 ± 
3.2b 
27.1 ± 4.5cd 
21.9 ± 
2.0bc 
32.9 ± 4.1c 
20.7 ± 
2.1bd 
16.4 ± 
4.0b 
8.0 ± 0.7a 
Liver Weight 
per Body 
Weight (%) 
x100 
2.6 ± 
0.1a 
3.6 ± 
0.1b 
3.4 ± 0.1b 3.6 ± 0.2b 3.2 ± 0.3b 
3.6 ± 
0.1b 
3.3 ± 0.2b 3.3 ± 0.2b 
Data are mean ± SEM; values with different letters are statistically different (p<0.05). 
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White Sorghum-Cowpea (WSC), WSC + Soy Protein Isolate (WSC+SPI), Over-processed WSC (O-WSC), O-WSC 
+ Soy Protein Isolate (O-WSC+SPI), White Sorghum- Soybean (WSS), Corn-Soybean Blend 14 (CSB14), Corn-
Soybean Blend + (CSB+). 
 
Table 2.10 Comparison of NRC broiler chicken nutrient requirements to FBFs 
ND: No data. NRC requirements from (105). 
Control chicken diet based on label values: 230.2 (kcal/100g), crude protein (22%), lysine (0.87%), methionine 
(0.43%), crude fat (2.5%), crude fiber (7.0%), calcium (1.0-1.1%), phosphorus (0.78%), salt (0.15-0.4%), sodium 
(0.01-0.3%); iron content analyzed in duplicate (41.5 mg/100g). 
FBF protein and amino acid values analyzed in duplicate by University of Missouri-Columbia Agricultural 
Experiment Station Chemical Laboratories, Columbia, MO. 
FBF iron content analyzed in duplicate by AIB International, Manhattan, KS. 
  
NRC 
0-21 
days 
NRC 
22-42 
days 
WSC 
WSC 
+SPI 
N-
WSC 
O-
WSC 
O-
WSC 
+SPI 
WSS 
CSB 
14 
CSB+ 
kcal/100g 320 320 412.8 418.4 402.7 403.02 401.7 411.7 429.5 384.8 
Amino Acids  g/100g       
Crude Protein 23 20 19.07 19.76 18.12 17.92 18.37 19.51 18.37 15.78 
Arginine 1.25 1.1 0.89 1.31 0.87 1 1.14 0.92 0.82 0.98 
Glycine + 
serine 
1.25 1.14 1.44 1.65 1.35 1.38 1.46 1.54 1.37 1.29 
Histidine 0.35 0.32 0.47 0.53 0.46 0.48 0.51 0.45 0.42 0.41 
Isoleucine 0.8 0.73 0.99 0.9 0.95 0.81 0.8 1.06 0.98 0.66 
Leucine 1.2 1.09 1.87 1.68 1.78 1.61 1.58 2.06 1.86 1.43 
Lysine 1.1 1 1.34 1.18 1.35 1.08 1.04 1.33 1.2 0.82 
Methionine 0.5 0.38 0.33 0.27 0.31 0.28 0.26 0.34 0.32 0.25 
Methionine + 
cysteine 
0.9 0.72 0.63 0.48 0.6 0.47 0.44 0.7 0.65 0.52 
Phenylalanine 0.72 0.65 0.89 1.08 0.86 0.94 1.02 0.9 0.82 0.78 
Phenylalanine 
+ tyrosine 
1.34 1.22 1.43 1.68 1.38 1.47 1.58 1.51 1.37 1.29 
Proline 0.6 0.55 0.93 0.9 0.83 0.78 0.78 1.17 1.04 0.92 
Threonine 0.8 0.74 0.97 0.7 0.91 0.71 0.65 0.98 0.92 0.57 
Tryptophan 0.2 0.18 0.3 0.25 0.28 0.24 0.22 0.32 0.31 0.2 
Valine 0.9 0.82 1.04 1 1 0.93 0.93 1.09 0.98 0.77 
Selected 
minerals 
mg/100g 
 
 
 
   
Calcium 1000 900 279.1 279.1 279.1 279.1 279.1 279.1 279.1 452 
Nonphytate 
phosphorus 
450 350 291 291 291 291 291 291 291 290 
Iron 8 8 17.2 16.8 16.15 16.45 16.75 15.85 16.0 10.45 
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FBF calcium and nonphytate phosphorus values based on Kansas State University proposed commodity 
specifications sheets. 
White sorghum-cowpea (WSC), Non-extruded WSC (N-WSC), WSC + soy protein isolate (WSC+SPI), Over-
processed WSC (O-WSC), Over-processed WSC + soy protein isolate (O-WSC+SPI), White sorghum-soy (WSS), 
Corn-soy blend 14 (CSB14), Corn-soy blend plus (CSB+). 
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 Figures 
 Prepared FBF Study 
 
Figure 2.1 Average weekly food intake for Prep study (n=10). 
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Figure 2.2 Average weekly body weights for Prep study (n=10). 
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 Dry FBF Study 
 
Figure 2.3 Average weekly food intake for Dry study (n=24, control n=23). 
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Figure 2.4 Average weekly body weights for Dry study (n=24, control n=23). 
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Chapter 3 - Final Conclusions and Future Directions 
The assessment of new FBFs compared to CSB+ in vivo in the chicken model allowed us 
to observe the nutritional quality of these products in a cost-effective model, to further refine and 
identify better FBF formulations in the continued effort to improve undernutrition through these 
products. Although in the Prep study, the chicken model did not allow us to control for certain 
environmental conditions, in the Dry study chickens were more robust. In a potential future study 
comparing FBFs nutritional quality in chickens, it may be worthwhile to design the study to 
include two groups for each FBF; one group fed normal FBF, and one group fed FBF plus a 
supplement that would meet chicken nutrient requirements. This could prevent limitations, such 
as gait issues, to better compare protein quality and iron bioavailability outcomes of FBFs in a 
healthier chicken model. 
As far as improving FBFs, suggestions made by the FAQR were supported in this study 
including sorghum and cowpea containing FBFs being effective alternatives to corn and soy, and 
extrusion processing improving nutritional quality compared to CSB+. Soy protein was also as 
efficacious to whey protein in one comparison group, deeming it a cost-effective protein 
supplement for improving growth outcomes. Additionally, less expensive options with 
reformulation and over-processing of sorghum and cowpea with whey protein were a novel 
formulation that proved to be equally efficacious, and can be considered to make a more cost-
effective FBF. In a potential study, it would be interesting to look at increasing the level of soy 
flour to meet protein requirements, for example in a sorghum-soy FBF, without needing to add in 
any protein supplement, thus making an even more cost-effective FBF.  
Although these studies were a small part in the overall mission to improve food aid, we 
still obtained very interesting and valuable results, and I am very grateful to have been able to 
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contribute to the overall goal of this project. I look forward to further research determining the 
most effective FBF formulations for ultimately treating, and ideally preventing, undernutrition in 
children and other vulnerable populations. 
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